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1. INTRODUCTION 
1.1. Colorectal cancer 
1.1.1. Epidemiology 
With over 1.8 million estimated incident cases and 881,000 estimated deaths in 2018, 
colorectal cancer (CRC) is the third most common cancer and the second most common 
cause of cancer-related death worldwide (Bray et al., 2018). Colorectal cancer incidence 
rates are higher in men than in women (Bray et al., 2018; Siegel et al., 2017) and there is a 
strong increase of CRC incidence with age (DeSantis et al., 2014). Overall, the global CRC 
incidence varies strongly with the highest incidence rates in transitioned countries such as 
Europe, Australia/New Zealand, Northern America, and Eastern Asia and the lowest rates 
in transitioning countries such as Africa and Southern Asia (Bray et al., 2018). 
In Germany, colon cancer is the fifth most common cancer and the fourth most common 
cause of cancer-related death, whereas rectal cancer is the ninth most common cancer and 
the seventh most common cause of cancer-related death. In 2018, it is estimated that 
58,047 individuals are diagnosed with CRC and 26,758 will die from the disease (Ferlay et 
al., 2018). Also, in Germany incidence rates are higher in men than in women with incident 
cases of 33,120 vs. 27,890 in 2014. Further, the risk of CRC also increases with age 
demonstrated by more than half of all CRC patients being diagnosed beyond age 70 and 
only 10% before age 50. The medium age of diagnosis in 2014 was 75 years for women 
and 72 years for men. Age-standardized incidence rates and mortality rates have been 
decreasing since 2003, with a decline in mortality by more than 20% within the last ten years 
(Robert Koch-Institut and die Gesellschaft der epidemiologischen Krebsregister in 
Deutschland, 2017). 
1.1.1.1. Colorectal cancer survivors 
Although age-standardized incidence and mortality rates have been declining (Robert Koch-
Institut and die Gesellschaft der epidemiologischen Krebsregister in Deutschland, 2017), 
the number of cancer survivors is continuously rising. This is traced back to earlier detection 
and improvements in cancer treatment as well as the aging of the population (DeSantis et 
al., 2014; Miller et al., 2016). In Germany, the relative five-year CRC survival rate has risen 
from 52% in 1991 (Brenner et al., 2005) up to 62% in the year 2014 (Robert Koch-Institut 
and die Gesellschaft der epidemiologischen Krebsregister in Deutschland, 2017). Tumor 
stage is a highly relevant determinant of CRC prognosis. Relative five-year survival rates of 
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90.3% are observed for CRC survivors with a localized stage, 70.4% for regional stage, and 
12.5% for distant stage (DeSantis et al., 2014). 
According to the National Coalition for Cancer Survivorship, a cancer survivor is any 
individual with a cancer history from diagnosis throughout the rest of her or his life  
(Leigh and Logan, 1991). Although there is no official definition of long-term survivorship, 
the majority of pertinent studies define cancer patients who are still alive five years after 
their diagnosis as long-term survivors (Bloom et al., 2007; Deimling et al., 2006; Jansen et 
al., 2010; Thong et al., 2013). This definition was established because cancer survivors 
without a recurrence five years after diagnosis are considered to be cured as their chance 
of mortality is often comparable to the one of the general population (Dickman and Adami, 
2006). 
1.1.2. Treatment 
In Germany, recommendations regarding CRC treatment are based on the S3-guideline 
“colorectal cancer”, developed by the Scientific Medical Professional Societies, the German 
Cancer Society, and the German Cancer Aid. This guideline aims to support physicians in 
giving evidence-based treatment advice to their patients and to safeguard the highest level 
of care (Schmiegel et al., 2017). 
If feasible, the resection of the tumor is the primary treatment option for CRC and is 
independent of tumor stage (Union for International Cancer Control [UICC]) and tumor site 
(colon or rectum), whereas recommendations on neoadjuvant and adjuvant therapy highly 
depend on tumor stage, tumor site, and specific risk factors (Schmiegel et al., 2017). 
As part of surgery, a stoma may need to be created in specific cases. If the tumor is located 
in the colon or in the upper or medium third of the rectum, a stoma is usually not necessary. 
In case of a tumor in the lower third of the rectum and a distance of less than 1-2 cm between 
the tumor and the anus, a stoma is required. If the sphincter muscle can be preserved, but 
the seam is located closely to the anus, a stoma will be necessary for a short period of time 
to improve wound healing. In cases where the tumor is located too closely to or is growing 
into the sphincter muscle a permanent stoma is necessary (Schmiegel et al., 2017). 
For patients with stage I colon cancer, no adjuvant therapy is indicated. So far, study results 
regarding benefits of adjuvant chemotherapy for patients with stage II colon cancer have 
been inconclusive. Therefore, possible benefits and risks of chemotherapy should be 
discussed with the patient. In case of microsatellite instability, no adjuvant therapy is 
recommended for stage II colon cancer patients. Those stage II colon cancer patients with 
prognostically unfavorable risk factors such as a T4 tumor, a tumor perforation/tears, an 
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emergency operation, or an insufficient number of lymph nodes examined, might benefit 
from adjuvant chemotherapy and it should therefore be considered. If chemotherapy is 
administered, a monotherapy with fluoropyrimidines is recommended. For patients with 
stage III colon cancer, adjuvant chemotherapy treatment including oxaliplatin (FOLFOX 
scheme) is recommended. If there is a contraindication to oxaliplatin, a monotherapy with 
fluoropyrimidines such as 5-Fluorouracil (5-FU) and folinic acid can be administered. 
Treatment of stage IV colon cancer patients highly depends on the general health condition 
of the patient, the metastasis spread, and specific tumor characteristics, therefore no 
universal recommendations are given. If surgery is not possible or if the tumor and/or 
metastases cannot be fully resected, treatment primarily with chemotherapy can be 
administered to prolong life and mitigate symptoms (Schmiegel et al., 2017). 
In general, there is no age limitation regarding chemotherapy treatment. Contraindications 
for adjuvant chemotherapy of colon cancers include poor health status, an uncontrolled 
infection, cirrhosis of the liver (Child-Pugh Score B and C), severe coronary heart disease 
or cardiac insufficiency, kidney insufficiency (preterminal and terminal), confined bone 
marrow functioning, other life expectancy affecting comorbidities, and the inability to 
participate in regular control check-ups (Schmiegel et al., 2017). 
In stage I rectal cancer patients, no neoadjuvant or adjuvant therapy is administered. 
Recommendations for stage II and III rectal cancer include neoadjuvant radiotherapy or 
neoadjuvant radiochemotherapy containing either oral capecitabin or 5-FU by infusion. A 
resection of cT1/2 and cT3a/b tumors prior to treatment should be considered in case of 
specific tumor characteristics. For stage II and III rectal cancer patients who did not receive 
neoadjuvant treatment, adjuvant radiochemotherapy or adjuvant chemotherapy should be 
administered following recommendations for colon cancer. Since studies showed adjuvant 
radiochemotherapy to be less effective and associated with more side effects compared to 
neoadjuvant radiochemotherapy, it should only be administered in stage II and III rectal 
cancer patients with histopathologic confirmed risk factors. Study results regarding benefits 
of adjuvant chemotherapy after neoadjuvant radiochemotherapy in rectal cancer patients 
have been inconclusive and therefore no universal recommendation is available. For stage 
IV rectal cancer patients, treatment is applied as recommended for stage IV colon cancer 
patients (Schmiegel et al., 2017). 
In general, if the tumor is located in the upper third of the rectum and there is no risk 
constellation for a local recurrence, therapy should be administered as recommended for 
colon cancer (Schmiegel et al., 2017). 
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1.1.2.1. Side effects of colorectal cancer treatment 
Colorectal cancer survivors experience treatment side effects during treatment, following 
treatment (long-term effects), and some effects can even occur several years later (late 
effects) (American Cancer Society, 2017). However, problems are reported to be most 
prominent during the first three years (Denlinger and Barsevick, 2009). 
Side effects from surgery can include urogenital or sexual dysfunction and fatigue, which 
might be present for a long period of time. Especially for rectal cancer patients, side effects 
such as a change in bowel movements, diarrhoea, constipation, gas or bloating are 
common (American Cancer Society, 2017). Patients with a stoma may experience 
complications such as a para-stomal hernia, leakage, dermatitis, obstruction, prolapse, 
retraction, or anastomotic leakage after stoma closure (Kuipers et al., 2015). 
Chemotherapy can lead to side effects such as fatigue, mental deficits (American Cancer 
Society, 2017) including oxaliplatin induced peripheral neuropathy (Denlinger and 
Barsevick, 2009), nausea and vomiting, hair loss, loss of appetite, mouth scores, swelling 
and rashes, a higher risk of infection due to low white blood cells, or numbness, tingling, or 
blistering of the hands and feet which most commonly occur after treatment including 
oxaliplatin (American Cancer Society, 2017). While some of the side effects go away after 
treatment, others such as numbness of hand and feet (American Cancer Society, 2017) or 
neuropathy (Denlinger and Barsevick, 2009) may persist. 
After radiation, side effects such as nausea, diarrhoea, fatigue, skin irritation, or sexual 
problems can occur. Symptoms like rectal irritation, rectal inflammation, or bladder irritation 
can lead to the urgency of frequent defecation and urination as well as pain. After treatment 
completion most of these side effects go away but some such as rectal or bladder irritation 
or sexual problems may persist permanently (American Cancer Society, 2017). Possible 
late effects of radiation include bowel dysfunction (Denlinger and Barsevick, 2009) like 
intestinal obstruction, bone fractures at the base of the spine, or infertility. Radiation also 
increases the risk of second cancers (American Cancer Society, 2017). 
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1.2. Health-related quality of life 
Research on quality of life (QOL) exists since the 1960s (Schuessler and Fisher, 1985). 
Since its introduction in research, there has been growing awareness of the concept of QOL 
in several disciplines such as sociology, politics, psychology, economics (Schuessler and 
Fisher, 1985), philosophy, and medicine (Daig and Lehmann, 2007). In medicine, the 
concept of QOL was integrated in the 1970/80s (Elkinton, 1966; Spitzer, 1987) and has 
played an important role in this field ever since (Bullinger, 2014). Also in oncology it has 
become clear that objective measures such as survival should not be the only endpoints of 
interest but also the QOL of cancer patients should be considered in treatment decisions 
(Jacobsen and Jim, 2011; Spitzer et al., 1981; Ware, 1995). The first QOL instruments were 
applied in research in the 1990s. Todays´ challenge is to integrate study findings into health 
care (Bullinger, 2014) which is emphasized by more than 300,000 search results for “quality 
of life” in Pubmed. 
1.2.1. Definition 
Although several definitions of QOL exist, there is not one universally accepted definition 
(Daig and Lehmann, 2007). The World Health Organization (WHO) defines QOL as an 
“individual's perception of their position in life in the context of the culture and value systems 
in which they live and in relation to their goals, expectations, standards and concerns” 
(World Health Organization, 1995). In QOL research, an operational definition which defines 
QOL as a multidimensional concept, is widely spread. Multidimensional QOL mostly 
comprises physical, emotional, social (Bullinger, 2014; Fayers and Machin, 2000), mental, 
and role aspects (Bullinger, 2014). In medical research, the concept of health-related QOL 
(HRQOL) is well accepted (Bullinger, 2000). It was introduced in clinical research to 
differentiate aspects of QOL which affect health, from overall QOL which includes a broader 
sense of well-being (e.g. happiness, satisfaction with life) that is subjective and therefore 
challenging to measure (Centers for Disease Control and Prevention, 2000). However, 
HRQOL, health, and QOL are often used interchangeably and definitions often fail to 
differentiate HRQOL from health and QOL (Karimi and Brazier, 2016). Therefore, Karimi et 
al. suggest “a clearer use of HRQOL would be to use it only to signify empirical studies of 
how health affects QOL or to signify the utility associated with a health state” (Karimi and 
Brazier, 2016). Throughout this dissertation QOL is always considered in the context of 
HRQOL. 
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1.2.2. Assessment of quality of life 
In medical research, QOL is usually assessed by self-report (Kohlmann, 2014). Since 
studies found that cancer patients´ reported QOL often differed from the perceptions of 
external observers (e.g. nurses, physicians, family) (Horton, 2002; Jones et al., 2011; 
Sneeuw et al., 1999), external QOL assessments should only be used if an individual is 
unable to communicate. Although several computer-based QOL applications have been 
developed in the last years such as the Patient-Reported Outcomes Measurement 
Information System (PROMIS) which provides applications including computerized 
adaptive testing (Cella et al., 2007), standardized paper-pencil measures are still frequently 
used. Quality of life measures can be classified in generic and disease-specific measures. 
Generic measures assess the QOL of individuals, independent of the existence of a 
disease, whereas, disease-specific measures additionally assess the patients´ QOL 
depending on possible detriments as a result of specific diseases (Kohlmann, 2014). 
Generic measures allow comparisons of patients´ QOL with patients of other diseases as 
well as with the general population, however, they lack the sensitivity of assessing specific 
symptoms patients may suffer from (Jacobsen and Jim, 2011). 
1.2.2.1. Generic measures 
Examples for generic measures are the Short-Form Health Survey (SF-36) (Ware and 
Sherbourne, 1992), the Nottingham Health Profile (NHP) (Hunt and McEwen, 1980; Hunt 
et al., 1981), and the World Health Organization Quality of Life Questionnaire (WHOQOL) 
(World Health Organization, 1995). One of the generic measures mostly used is the SF-36 
(Bullinger, 2014), which has been translated into more than 40 languages (Daig and 
Lehmann, 2007). The SF-36 was developed within the Medical Outcome Study to assess 
the health status within clinical practice, research, health policy evaluations as well as in 
general population surveys. It consists of 36 items which measure the health status on eight 
scales: physical functioning, role limitations due to physical problems, social functioning, 
bodily pain, general mental health, role limitations due to emotional problems, vitality, and 
general health perceptions. The eight scales can be classified into two main dimensions: 
the physical and the mental health component score (Ware and Sherbourne, 1992). In 
addition, short forms such as the SF-12 are available (Ware et al., 1996). 
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1.2.2.2. Disease-specific measures 
Disease-specific measures cover a wide range of diseases such as cancer, HIV, or skin 
disorders. Examples are the Quality of Life Questionnaire-Core 30 (QLQ-C30) of the 
European Organization for Research and Treatment of Cancer (EORTC) (Aaronson et al., 
1993), the Functional Assessment of Cancer Therapy-General (FACT-G) (Cella et al., 1993; 
Webster et al., 2003), the Patient Reported Outcomes Quality of Life-HIV (PROQOL-HIV) 
(Duracinsky et al., 2012), and the Psoriasis Index of Quality of Life (PSORIQoL) (McKenna 
et al., 2003). The QLQ-C30 is a measure widely used and well accepted to assess the 
disease-specific QOL in cancer patients (Bullinger et al., 2006; Deutschinoff et al., 2005). 
The core instrument QLQ-C30 consists of five functional scales (physical, role, cognitive, 
emotional, and social), three symptom scales (fatigue, pain, and nausea and vomiting), and 
a global health and QOL scale. Also, six single items which include further symptoms and 
problems (dyspnoea, insomnia, appetite loss, constipation, diarrhoea, and financial 
difficulties) are available (Aaronson et al., 1993). The EORTC study group also provides 
cancer site-specific modules such as the QLQ-CR38 (Sprangers et al., 1999) for CRC and 
its updated version QLQ-CR29 (Gujral et al., 2007; Whistance et al., 2009). 
Cancer-specific measures were mostly designed to assess QOL in cancer patients shortly 
after diagnosis or treatment and thus might assess aspects that are no longer relevant for 
cancer survivors such as nausea and vomiting (van Leeuwen et al., 2018). Further, those 
measures might lack problems which are relevant to cancer survivors specifically in the 
years after diagnosis for example fear of recurrence or return to work (van Leeuwen et al., 
2018). Therefore, measures have been developed or are currently being developed which 
specifically assess issues relevant to cancer survivors. 
The Quality of Life in Adult Cancer Survivors (QLACS) was designed to assess QOL in 
long-term cancer survivors. The QLACS comprises 47 items of which 28 items assess 
generic domains and 19 items cancer-specific domains. The generic domains include 
positive and negative feelings, cognitive and sexual problems, physical pain, fatigue, and 
social avoidance, whereas the cancer-specific domains comprise appearance concerns, 
financial problems, distress over recurrence, family-related distress, and benefits of cancer 
(Avis et al., 2005). 
Currently the EORTC is developing a QOL questionnaire for cancer survivors who have 
been disease free for at least one year after treatment. The aim is to additionally provide a 
survivorship questionnaire assessing not only psychosocial aspects of QOL in cancer 
survivors, but also more detriments in QOL caused by chronic physical side effects of 
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cancer and its treatment. A core questionnaire as well as three modules for specific cancer 
sites are currently being tested (van Leeuwen et al., 2018). 
1.2.3. Quality of life in long-term colorectal cancer survivors 
As already mentioned, the number of cancer survivors is steadily increasing due to aging 
of the population and improvements in early detection and treatment (DeSantis et al., 2014; 
Miller et al., 2016). Thus, the QOL of this growing population is a highly relevant issue. Many 
cancer survivors suffer from symptom burden and detriments in QOL not only during or right 
after determining treatment, but also long into survivorship (Arndt et al., 2017; Arndt et al., 
2006; Wu and Harden, 2015). 
In CRC survivors, detriments in QOL were found up to 15 years after diagnosis (Caravati-
Jouvenceaux et al., 2011). Although the overall QOL among long-term CRC survivors was 
reported to be comparable to the QOL of the general population (Caravati-Jouvenceaux et 
al., 2011; Jansen et al., 2010; Trentham-Dietz et al., 2003), the sequelae of cancer and its 
treatment can affect especially symptom-related QOL even years after diagnosis. 
Detriments were reported for long-term CRC survivors regarding social functioning 
(Caravati-Jouvenceaux et al., 2011; Jansen et al., 2011a), physical QOL (Jansen et al., 
2010), depression, distress related to cancer (Jansen et al., 2010), anxiety, body image, 
sexual function, impotence (Bailey et al., 2015), bowel problems (Jansen et al., 2010) such 
as diarrhoea (Caravati-Jouvenceaux et al., 2011; Jansen et al., 2011a) or embarrassment 
by bowel movements, and micturition problems (Bailey et al., 2015). 
Comparing younger and older long-term CRC survivors, younger survivors reported worse 
mental QOL (Adams et al., 2016), anxiety, and a lower body image (Bailey et al., 2015), 
whereas older survivors scored significantly lower on physical QOL (Adams et al., 2016) 
and sexual function (Bailey et al., 2015). Lower QOL was reported among long-term CRC 
survivors having one or more comorbidities (Adams et al., 2016; Caravati-Jouvenceaux et 
al., 2011; Ramsey et al., 2002; Sapp et al., 2003), a lower income (Caravati-Jouvenceaux 
et al., 2011; Lundy et al., 2009; Ramsey et al., 2000; Ramsey et al., 2002), being physically 
inactive (Lynch et al., 2016; Rodriguez et al., 2015; Thraen-Borowski et al., 2013), a smoker, 
or obese (Adams et al., 2016). Further, rectal cancer survivors with a permanent stoma 
were reported to have a QOL inferior to rectal cancer patients without a stoma (Fucini et al., 
2008; Krouse et al., 2009; Näsvall et al., 2017). Inconsistent results have been reported 
regarding stage and QOL in long-term CRC survivors (Adams et al., 2016; Aminisani et al., 
2017; Pucciarelli et al., 2008; Ramsey et al., 2002). 
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The experience of cancer can also have positive consequences on the lives of survivors 
including phenomena such as post-traumatic growth or benefit finding (Chambers et al., 
2012a; Jansen et al., 2011b). 
1.2.4. Fatigue 
Fatigue is the most common and distressing symptom experienced by cancer patients 
during and after treatment (Ryan et al., 2007) and is still frequently reported by cancer 
survivors (Denlinger and Barsevick, 2009; Minton and Stone, 2009; Wu and Harden, 2015), 
even ten years post-diagnosis (Thong et al., 2013). Cancer patients suffering from fatigue 
are often not able to perform activities of everyday life, which can negatively affect their 
social relationships (Hofman et al., 2007; Scott et al., 2011) and QOL (Butt et al., 2008; 
Cheng and Lee, 2011; Hofman et al., 2007; Ness et al., 2013). 
Fatigue is also prevalent among CRC survivors (Jensen et al., 2011; Pucciarelli et al., 2011; 
Wang et al., 2012). Although fatigue is commonly reported in the general population, the 
fatigue experience of short- as well as long-term CRC survivors is described to be more 
severe (Caravati-Jouvenceaux et al., 2011; Jansen et al., 2011a; Thong et al., 2013). 
Although fatigue has been associated with cancer, its treatment, symptoms such as 
depression or poor sleep as well as with lifestyle factors (Brown and Kroenke, 2009; George 
et al., 2014; Grimmett et al., 2011; Roscoe et al., 2007; Schmidt et al., 2015; Wang and 
Woodruff, 2015), the underlying causal mechanisms of fatigue are still not fully understood 
(Barsevick et al., 2013; Saligan et al., 2015; Wang and Woodruff, 2015). There have been 
diverse conceptual and operational definitions of fatigue and there is no consensus on how 
it should be measured (e.g. unidimensional vs. multidimensional). The variability of study 
outcomes has hampered comparisons of study findings and thus their generalizability for 
clinical practice (Barsevick et al., 2013; Minton and Stone, 2009). 
Although there is not one universally accepted definition of cancer-related fatigue (Minton 
and Stone, 2009), the following definition of the National Comprehensive Cancer Network 
is widely used: “cancer-related fatigue is a distressing persistent, subjective sense of 
physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer 
treatment that is not proportional to recent activity and interferes with usual functioning” 
(Berger et al., 2010). 
Self-report measures that are often used to assess fatigue, mostly incorporate one or more 
aspects of this definition. Apart from the physical, cognitive, and affective domains, other 
domains such as motivation, energy or vitality, or diurnal variation have been measured 
(Barsevick et al., 2010). Unidimensional scales only assess the physical aspect, whereas 
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multidimensional scales cover different aspects of fatigue (Minton and Stone, 2009). An 
example of a unidimensional assessment of fatigue is included in the QLQ-C30. The 
EORTC has further developed a multidimensional fatigue module, the QLQ-FA12 which 
assesses physical, cognitive, and emotional fatigue (Weis et al., 2017). The Fatigue 
Assessment Questionnaire (FAQ) also multidimensionally assesses physical, cognitive, 
and affective fatigue (Glaus and Muller, 2001). 
Although the multidimensional concept of fatigue is widely accepted (de Raaf et al., 2013), 
some studies have suggested that the different fatigue dimensions might not be expressions 
of one symptom but rather expressions of independent symptoms (multiple-symptom 
concept) (de Raaf, 2013). A recent review article found that physical and mental fatigue 
behaved differently in some studies and therefore concludes that further research on the 
multiple-symptom concept should be performed to clarify the concept of fatigue (de Raaf et 
al., 2013). 
Interventions to reduce fatigue mostly supported in the literature include the treatment of 
additional medical conditions (e.g. anemia) or symptoms (e.g. depression, insomnia, pain), 
psychosocial interventions such as fatigue self-care or coping techniques, and exercise 
(Pachman et al., 2012). 
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1.3. Physical activity 
Industrial progress and technological innovation have contributed to a collectively sedentary 
lifestyle of individuals, not only in the Western world (Hills et al., 2015). However, the human 
body is designed for being physically active (Booth et al., 2008) and there is strong evidence 
that physical inactivity is associated with an increase of several non-communicable 
diseases. According to the WHO, physical inactivity is the fourth leading risk factor for 
mortality worldwide (World Health Organization, 2009). Therefore, being physically active 
is a highly relevant issue. 
1.3.1. Definition 
A frequently cited definition of physical activity (PA) is the one of Caspersen et al. which 
describes PA “as any bodily movement produced by skeletal muscles that results in energy 
expenditure” (Caspersen et al., 1985). Physical activity comprises all activities carried out 
in daily life including leisure time, occupation, transportation, household chores, or planned 
exercise (World Health Organization, 2010). The terms PA and exercise should not be 
confused since “exercise is a subset of physical activity that is planned, structured, and 
repetitive and has as a final or an intermediate objective the improvement or maintenance 
of physical fitness” (Caspersen et al., 1985). 
1.3.2. Operationalization of physical activity 
Physical activity can be categorized into four dimensions including the type, frequency, 
duration, and intensity of activities. The type describes the specific activity performed, the 
frequency describes the number of bouts per day or week, the duration describes the 
amount of minutes or hours spent, and the intensity describes the energy expenditure of 
activities (Strath et al., 2013). The intensity of PA can be measured in kilocalories, oxygen 
consumption, joules, or metabolic equivalent values (METs) which are frequently used in 
research (Physical Activity Guidelines Advisory Committee, 2018). One MET is defined as 
the energy consumed while sitting quietly (resting metabolic rate), which is comparable with 
an oxygen consumption of 3.5 milliliters per kilogram per minute. The energy expenditure 
of activities is expressed as multiples of the resting metabolic rate (Ainsworth et al., 1993), 
for example 7.5 METs for bicycling, general; 7.0 METs for jogging, general; 4.8 METs for 
golfing, general; 2.5 METs for slow walking (Ainsworth et al., 2011). The dose of PA can be 
derived by multiplying the dimensions of frequency, duration, and intensity whereas the 
volume of PA is the quantification of the dose over a specific period of time (Physical Activity 
Guidelines Advisory Committee, 2018; Strath et al., 2013) and is commonly expressed in 
MET hours or MET minutes per week or day (Physical Activity Guidelines Advisory 
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Committee, 2018). Four categories of PA intensities have been commonly used: vigorous 
PA, moderate PA, light PA, and sedentary time. Vigorous PA includes energy costs of ≥6 
METs (e.g. jogging), moderate PA of 3.0-5.9 METs (e.g. golfing), and light PA of 1.1-2.9 
METs (e.g. slow walking) (U.S. Department of Health and Human Services, 2008). 
Sedentary behavior comprises energy costs of 1.0-1.5 METs (e.g. watching television) 
(Ainsworth et al., 2011; Garber et al., 2011), whereas physical inactivity is defined as not 
being physically active beyond activities which are needed in everyday life (U.S. 
Department of Health and Human Services, 2008). 
The first studies on PA and coronary heart disease, only assessed occupational PA 
(Dishman et al., 2012, p. 37-70), however, since the decline of occupations requiring hard 
PA, research has focused more and more on leisure time PA (Lamb and Brodie, 1990; 
Morris et al., 1980). Nowadays, the PA domains mostly assessed include occupational and 
leisure time PA as well as domains such as transportation and household PA (Physical 
Activity Guidelines Advisory Committee, 2018; Strath et al., 2013). 
1.3.3. Health benefits 
There is strong evidence that individuals engaging in regular PA have several physical and 
mental health benefits (Hills et al., 2015) which include health conditions such as coronary 
heart disease (Kyu et al., 2016; Sattelmair et al., 2011; Sofi et al., 2008), hypertension (Huai 
et al., 2013), stroke (Kyu et al., 2016; Lee et al., 2003; Wendel-Vos et al., 2004), diabetes 
(Aune et al., 2015; Kyu et al., 2016), obesity (Shaikh et al., 2015), musculoskeletal health 
(Bolam et al., 2013; Marques et al., 2012), psychological health (Gill et al., 2013; Martinsen, 
2008; Rosenbaum et al., 2014), functionality, balance (Chou et al., 2012), and all-cause 
and cardiovascular mortality (Woodcock et al., 2011; Wu et al., 2015). 
Furthermore, associations have been found between PA and numerous cancers (Behrens 
et al., 2018; Kyu et al., 2016; Robsahm et al., 2013). There is strong evidence that increased 
PA decreases the risk of colon, breast (Physical Activity Guidelines Advisory Committee, 
2018; Steindorf, 2013), bladder, endometrium, esophagus, kidney, stomach, and lung 
cancer. Moreover, a dose-response relationship between PA and lower risk of breast and 
colon cancer exists (Physical Activity Guidelines Advisory Committee, 2018). 
In general, there is evidence of a dose-response relationship not only for PA and cancer but 
also for several health outcomes. This implies that higher levels of PA are most beneficial 
for health, whereas a lower level is better than inactivity (Garber et al., 2011). However, the 
exact shape of the dose-response curve is not entirely understood and may be dependent 
on the starting level of PA and the specific health outcomes (Haskell et al., 2007). For 
example it has been reported that the greatest benefits on health was for sedentary people 
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becoming more physically active (Hills et al., 2015). The minimum level of PA that is 
beneficial for health has not been extensively explored (Hills et al., 2015) and without 
considering the minimum PA levels, most research has concentrated on moderate to 
vigorous PA. However, due to improvements in objective PA measures such as 
accelerometers, the contribution of light PA independently of moderate to vigorous PA is 
nowadays accurately measurable. Therefore, the associations between light PA and health 
benefits are reported more and more (LaMonte et al., 2017; Powell et al., 2011). 
In addition to the accumulating evidence of the beneficial health effects of PA, a recent 
report summarizing systematic reviews found strong evidence for the association between 
sedentary behavior and all-cause mortality, cardiovascular disease, type 2 diabetes, and 
metabolic syndrome. Moderate evidence was reported for the association between 
sedentary behavior and ovarian, endometrial, and colon cancer. The report also concluded 
that sedentary behavior might be associated with health, independent of PA (de Rezende 
et al., 2014). Furthermore, two meta-analyses reported that the increased risk of all-cause 
mortality associated with sedentary behavior may be attenuated but not eliminated by 
higher levels of PA (Biswas et al., 2015; Ekelund et al., 2016). 
Several biological mechanisms have been suggested to be responsible for the health 
benefits of PA on chronic diseases. Physical activity has been shown to reduce abdominal 
adiposity and help maintain a healthy weight, improve lipoprotein profiles (e.g. by increasing 
high density lipoprotein cholesterol), glucose homeostasis, and insulin sensitivity as well as 
endothelial function, decrease blood pressure, and systemic inflammation. Cancer-specific 
effects of PA relate to decreases in fat stores, changes in immune function, insulin and 
insulin-like growth factors, levels of sex hormones, and production of free-radicals 
(Warburton et al., 2006). According to a recent review, the health benefits of PA for chronic 
stress- and inflammatory-related diseases include the improved communication, activation, 
and recovery of the neuroendocrine, inflammatory, and metabolic stress response 
pathways (Silverman and Deuster, 2014). 
1.3.4. Physical activity recommendations 
Due to the positive health effects of PA, the first PA recommendations were published by 
the Centers for Disease Control and Prevention, and the American College of Sports 
Medicine (ACSM) in 1995 (Pate et al., 1995). Since then, several qualified organizations 
such as the American Cancer Society (ACS) (Kushi et al., 2012) and government agencies 
such as the Department of Health and Human Services (HHS) (U.S. Department of Health 
and Human Services, 2008) have developed PA recommendations, for example the HHS´ 
2008 Physical Activity Guidelines for Americans. The first PA recommendations from 1995 
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were updated by the ACSM together with the American Heart Association in 2007 (Haskell 
et al., 2007). Recently, the HHS published an updated PA report, which will be used to 
develop the second version of the Physical Activity Guidelines for Americans (Physical 
Activity Guidelines Advisory Committee, 2018). 
According to the Physical Activity Guidelines for Americans, adults aged 18 years or older 
should engage in at least 150 minutes of moderate intensity aerobic PA or 75 minutes of 
aerobic vigorous intensity PA, or an equivalent combination of both activities throughout the 
week (U.S. Department of Health and Human Services, 2008). An increase up to 300 
minutes of moderate and 150 minutes of vigorous PA per week or an equivalent 
combination of both go along with additional health benefits. Activities should be performed 
for at least 10 minutes, and muscle strengthening should be performed at least twice per 
week. Adults aged 65 years and older with mobility problems should carry out activities 
improving balance to prevent falls. In general, older adults should orient their PA on their 
conditions and abilities (U.S. Department of Health and Human Services, 2008). According 
to the ACSM and the ACS, cancer survivors should engage in the same amounts of PA 
recommended for the general population during and after treatment receiving assistance 
(Rock et al., 2012; Schmitz et al., 2010). 
1.3.5. Assessment of physical activity 
There are several strategies to assess PA such as questionnaires including diaries, recall 
questionnaires, or interviews, direct observation, measures of energy expenditure, 
physiological markers, and motion sensors (Strath et al., 2013; Westerterp, 2009). 
Subjective measures such as questionnaires or interviews based on self-report are a 
common and practical method to assess PA in epidemiologic studies (Dishman et al., 2012, 
p. 37-70). Recall questionnaires frequently assess specific activity types or PA intensities, 
mostly moderate to vigorous PA. Often, questionnaires also include questions regarding 
sedentary time (Physical Activity Guidelines Advisory Committee, 2018), frequently 
assessed by the time watching television (Lynch et al., 2016). Examples for PA 
questionnaires that are frequently used in research are the International Physical Activity 
Questionnaire (IPAQ) (Craig et al., 2003), the Godin Leisure-Time Exercise Questionnaire 
(GLTEQ) (Godin and Shephard, 1985), or the Community Healthy Activities Model Program 
for Seniors (CHAMPS) (Stewart et al., 2001). The IPAQ asks for the number of days and 
minutes per week during which vigorous (8 METs) and moderate PA (4 METs), walking (3.3 
METs), and also sitting (1 MET) was performed. The IPAQ assesses time spent in activities 
across domains including occupation, leisure time, self-powered transport, household, and 
yard/garden. The short version contains nine items and the long version 31 items. 
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Objective PA measures include different approaches such as the doubly labeled water 
technique, calorimetry, heart rate monitoring, or motion sensors such as pedometers or 
accelerometers (Hills et al., 2014). Although the doubly labeled water technique is the gold 
standard due to its accurate and unobtrusive assessment of the energy expenditure, its 
application is not practical in most settings (Dishman et al., 2012, p. 37-70). However, the 
measurement of accelerometers has become more accurate assessing upper and lower 
body movements and its application is getting easier since devices are available in wrist 
watches and smart phone apps (Physical Activity Guidelines Advisory Committee, 2018). 
Some of these measures have been successfully paired, for example, accelerometers and 
heart rate monitoring (Brage et al., 2004; Haskell et al., 1993) and also multi-sensor systems 
exist which include a diversity of sensors and technologies (Physical Activity Guidelines 
Advisory Committee, 2018). 
Both, subjective as well as objective PA measures have advantages as well as 
disadvantages (Hills et al., 2014). The assessment of PA using questionnaires is time and 
cost efficient and enables the evaluation of rich descriptive data (Hills et al., 2014) among 
large populations (Dishman et al., 2012, p. 37-70). Further, it is adequate for ranking 
participants PA from low to high (Physical Activity Guidelines Advisory Committee, 2018). 
Shortcomings include that they rely on the recall ability of participants (Hills et al., 2014) 
and that they often miss out on the accuracy of the PA volume performed (Physical Activity 
Guidelines Advisory Committee, 2018). The accuracy of objective measures such as 
accelerometers in assessing physical movement is steadily increasing and the devices are 
getting more affordable, therefore, in epidemiological studies devices are more and more 
preferred over PA questionnaires (Physical Activity Guidelines Advisory Committee, 2018). 
However, some objective measures including accelerometers can only be used for specific 
activities such as walking and running (Hills et al., 2014). 
1.3.6. Physical activity in long-term colorectal cancer survivors 
The beneficial effects of PA for the primary prevention of cancer were described in section 
1.3.3. Moreover, evidence has accumulated that PA is also prognostically relevant for CRC 
patients. Physically active CRC survivors were reported to have significantly improved 
recurrence-free (Meyerhardt et al., 2006b; Walter et al., 2017) and overall survival (Baade 
et al., 2011; Meyerhardt et al., 2006a; Meyerhardt et al., 2006b; Walter et al., 2017). 
Aside from a better prognosis for physically active CRC survivors, studies reported PA to 
be positively associated with physical and psychological health. Survivors participating in 
prehabilitation programs including PA reported improvements in health outcomes after 
treatment such as fitness capacity (Gillis et al., 2014; Li et al., 2013; West et al., 2015). 
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Studies investigating PA after treatment showed that patients who were more physically 
active tended to report better overall QOL, better functioning (Grimmett et al., 2011; Husson 
et al., 2015; Mols et al., 2015; Rodriguez et al., 2015), less pain, insomnia (Mols et al., 
2015), and fatigue (Grimmett et al., 2011; Mols et al., 2015; Peddle et al., 2008; Vallance et 
al., 2014). Although a recent review article by Lynch et al. reported that observational 
studies unanimously observed associations between PA and QOL, the evidence is much 
weaker from intervention studies (Lynch et al., 2016). Also, a recent meta-analysis failed to 
show a significant association between PA and fatigue in randomized controlled trials, 
although in all studies PA was accompanied by reduced levels of fatigue (Brandenbarg et 
al., 2018). 
So far, most studies investigating the association between PA and QOL or fatigue have 
focused on short-term CRC survivors (less than five years post-diagnosis). However, as 
described in section 1.2.3, CRC survivors still experience detriments in QOL long into 
survivorship, therefore, it is of interest if PA is also beneficial for the QOL of long-term CRC 
survivors. Moreover, most studies cross-sectionally assessed the association between PA 
and QOL or fatigue after CRC diagnosis. However, it is also relevant to investigate if pre-
diagnosis PA has the potential to buffer detriments in QOL even years after diagnosis or if 
only ongoing PA after diagnosis is beneficial for long-term CRC survivors to improve QOL 
and decrease fatigue. 
Despite reported benefits of PA on CRC survivors´ health, a great number of CRC survivors 
do not meet recommended amounts of PA. In one study only one third of CRC survivors 
met PA recommendations and half of all survivors were totally inactive (Speed-Andrews et 
al., 2012). Moreover, CRC survivors were reported to have lower PA levels compared to 
other cancer survivors (Bellizzi et al., 2005) and one study reported that less than one 
quarter of CRC survivors participated in a sport last month (McGowan et al., 2013). Also, in 
two studies around 50-70% of long-term CRC survivors did not meet PA recommendations 
(Rodriguez et al., 2015; Thraen-Borowski et al., 2013). 
Therefore, it is also of great importance to investigate the potential determinants which keep 
CRC survivors from being physically active. More than half of all CRC patients are 
diagnosed beyond 70 years of age (Robert Koch-Institut and die Gesellschaft der 
epidemiologischen Krebsregister in Deutschland, 2017), thus, many CRC survivors may not 
be capable to engage in recommended levels of PA. Apart from age (Fisher et al., 2016; 
van Putten et al., 2016), other factors exist which have been shown to be associated with 
physical inactivity in CRC survivors such as disease-specific (Lynch et al., 2010) or 
treatment side effects (Courneya et al., 2005; van Putten et al., 2016), fatigue (Chambers 
et al., 2009; Courneya et al., 2005; Fisher et al., 2016; van Putten et al., 2016), pain, 
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psychological barriers such as anxiety and depressive symptoms (van Putten et al., 2016), 
and factors such as smoking or obesity (Chambers et al., 2009). Further, personal attributes 
such as lack of time (Courneya et al., 2005), fear of injury, or lack of enjoyment (Lynch et 
al., 2010; McGowan et al., 2013) have also been associated with physical inactivity. 
Although some studies have already investigated risk factors of physical inactivity in CRC 
survivors, in both cross-sectional (Fisher et al., 2016; McGowan et al., 2013) and 
longitudinal studies (Chambers et al., 2009; Courneya et al., 2005; Lynch et al., 2010; van 
Putten et al., 2016), none of these studies investigated physical inactivity specifically in long-
term CRC survivors. However, it has been reported that also long-term CRC survivors are 
not sufficiently active. Therefore, understanding potential determinants of physical inactivity 
in long-term CRC survivors has strong clinical and population health relevance. 
  
18 1 Introduction 
 
1.4. Aims of the dissertation 
The aim of this dissertation was to investigate if PA is positively associated with QOL and 
fatigue among long-term CRC survivors and to explore the potential determinants of 
physical inactivity among this population. Further, it was of interest to investigate at what 
point in time PA is most effective for improving the QOL and fatigue of long-term CRC 
survivors. The following objectives were addressed: 
• To review and summarize the literature on the association between PA and QOL in 
long-term CRC survivors. 
 
• To investigate the association of pre-diagnosis and post-diagnosis PA with QOL in 
long-term CRC survivors. 
 
• To investigate the association of pre-diagnosis and post-diagnosis PA with fatigue 
in long-term CRC survivors. 
 
• To investigate the potential determinants of physical inactivity in long-term CRC 
survivors. 
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2. MATERIAL AND METHODS 
2.1. Systematic review of the association between physical activity and 
quality of life in long-term colorectal cancer survivors 
2.1.1. Literature search 
The literature search was carried out in August 2016 and was repeated in January 2017 to 
guarantee inclusion of all relevant publications. The databases PubMed, Web of Science, 
PsychINFO, and CINAHL were searched for relevant articles. The exact combinations of 
search terms are listed in Appendix I. Cross-referencing was performed to identify additional 
articles which were not identified by the database search. 
2.1.2. Inclusion criteria 
To be included in the review, studies had to assess QOL in CRC patients five and more 
years post-diagnosis and PA within the time span of diagnosis to QOL assessment. Results 
of studies which investigated short-term as well as long-term survivors were also eligible if 
specific results for long-term survivors were provided. Studies comprising survivors with a 
mean of ≥5 years since diagnosis were also included. All types of CRC and all types of PA 
were eligible. However, QOL had to be assessed by more than one scale as it is a 
multidimensional concept. When studies investigated several cancer types, only the specific 
results for CRC survivors were included. Furthermore, PA had to be the independent 
variable and QOL the outcome variable. All types of quantitative original studies, published 
in English or German, were included. Conference abstracts, study protocols, editorials, 
commentaries, qualitative studies, theses, reviews, and meta-analyses were not 
considered. There was no restriction regarding the publication date. 
2.1.3. Data extraction 
Titles and abstracts of all identified articles were screened by myself. Subsequently the full 
texts of the selected articles were checked for eligibility. The study characteristics of the 
eligible studies (e.g. first author, year, journal, sample size, country, sex, age, tumor site, 
cancer stage, cancer treatment, sampling, study design, comorbidities, inclusion and 
exclusion criteria, baseline response rate, timing/type of PA assessment, timing/type of 
QOL assessment, confounders/adjustment, statistical methods, results) were 
independently extracted by myself and a second reviewer. Discrepancies were discussed 
and if they could not be solved, a third reviewer was involved. 
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2.1.4. Statistical significance and clinical relevance 
All statistically significant results mentioned in this review refer to a p-value <0.05. If studies 
reported clinical relevance using either the QLQ-C30 or the SF-36, the reported clinical 
relevance was adopted. For those studies using the QLQ-C30 and not reporting clinical 
relevance, clinical relevance was determined by using a medium clinical relevance, which 
is defined by Osoba et al. as a mean difference of ≥10 score points (Osoba et al., 1998). 
2.1.5. Combining the results of different quality of life instruments 
As the included studies used various QOL instruments with different notation for the 
embedded scales, results pertaining different QOL scales of different questionnaires were 
combined as shown in Table 1. 
Table 1 Combining the results of different quality of life instruments 
 Questionnaire Scale 
Global QOL QLQ-C30 (Aaronson et al., 1993) Overall QOL/ global health 
 SF-36 (Gandek et al., 2004) General health and global health 
composite score 
 EQ-5D (Revicki et al., 2009) Overall HRQOL 
   
Physical functioning QLQ-C30 Physical functioning 
 SF-36 Physical functioning and physical 
health composite score 
 FACT-C (Sprangers, 1999) Physical well-being 
 PROMIS (Hays et al., 2009) Physical HRQOL 
   
Role functioning QLQ-C30 Role functioning 
 SF-36 Role physical 
 FACT-C Functional well-being 
   
Social functioning QLQ-C30 Social functioning 
 SF-36 Social functioning 
 FACT-C Social well-being 
   
Emotional functioning QLQ-C30 Emotional functioning 
 SF-36 Mental health 
 FACT-C Emotional well-being 
QOL: quality of life; HRQOL: health-related QOL; QLQ-C30: Quality of Life Questionnaire-Core 30; SF-36: The Short Form 
Health Survey; EQ-5D: EuroQol five dimensions questionnaire; FACT-C: Functional Assessment of Cancer Therapy-
Colorectal Cancer; PROMIS: Patient-Reported Outcomes Measurement Information System 
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2.1.6. Quality assessment 
The methodological quality of each included article was checked by two reviewers using 
items adapted from the checklist of Mols et al., with a more detailed emphasis on contents 
that are important to the specific study question of my review (Mols et al., 2005). The 
following quality criteria were considered: 
• Information bias: 
• Adequate assessment of exposure (i.e. valid PA instrument, assessment of all 
PA aspects, objective measure rather than self-report) 
• Adequate assessment of outcome (i.e. valid QOL instrument, assessment of all 
relevant QOL aspects) 
• Adequate description of data (socio-demographic and medical data is described 
e.g. age, tumor stage at diagnosis etc.; the process of data collection is 
described e.g. interview or self-report) 
• Selection bias: 
• Inclusion and/or exclusion criteria are formulated 
• Healthy (survivor) participation bias (i.e. information about non-participants at 
baseline, information about drop-outs at follow-up, attrition bias) 
• Study design: 
• Description of timing of PA/QOL assessment 
• Adequate information regarding time since diagnosis 
• Adequate sample size and power 
• Prospective study design rather than cross-sectional 
• Correction of outcome measures for confounding (e.g. age, sex, comorbidities) 
This systematic review was guided by the criteria, set out by the PRISMA guidelines 
(Stewart et al., 2015). 
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2.2. The DACHS study 
2.2.1. Study design 
All empirical analyses of this dissertation are based on the study population of the DACHS 
(Darmkrebs: Chancen der Verhütung durch Screening) study. The DACHS study is an 
ongoing population-based case-control study with additional follow-up of CRC cases. The 
study is carried out in the southwest of Germany and currently includes over 6000 CRC 
patients and over 6000 controls, recruited since 2003. Eligible cases with a histologically 
confirmed diagnosis of primary CRC (International Classification of Diseases, 10th Revision 
[ICD-10] codes C18-C20) have to be older than 30 years at diagnosis, residents of the study 
region, German speaking, and physically and mentally able to participate in an interview of 
approximately one hour. The original study was designed to investigate the potentials of 
endoscopic screening for the reduction of CRC risk. Further details of the study have been 
described elsewhere (Brenner et al., 2011; Hoffmeister et al., 2015; Jansen et al., 2014; 
Walter et al., 2017). The DACHS study was approved by the ethics committees of the 
University of Heidelberg and the state medical boards of Baden-Wuerttemberg and 
Rhineland-Palatinate. All participants gave written informed consent. 
2.2.2. Study population 
In all analyses only CRC cases were included since no follow-up information for controls is 
available. For the analysis on determinants of physical inactivity, 1343 CRC survivors who 
were recruited between 2003 and 2008 and participated in the five-year follow-up (5YFU) 
between 2009 and 2014 were included. For the analyses on QOL and fatigue an updated 
dataset was available and therefore 1781 CRC survivors were included who had been 
recruited between 2003 and 2010 with a 5YFU participation date between 2009 and 2016. 
2.2.3. Data collection 
2.2.3.1. Assessment of baseline and follow-up information 
Patients with newly diagnosed CRC were identified by their treating clinician during their 
hospital stay and were interviewed in the hospital or contacted by mail shortly after their 
discharge by clinicians or clinical cancer registries. At baseline, socio-demographic 
information, medical, and lifestyle history were obtained by trained interviewers using a 
standardized questionnaire. Three years after diagnosis detailed information about 
treatment, other diseases, and recurrence was collected from attending physicians, 
using a standardized questionnaire. In order to obtain follow-up data including changes in 
lifestyle, medical or recurrence history, QOL, and fatigue, CRC patients were sent a 
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questionnaire by mail five years after diagnosis. Information about recurrence, other 
diseases, and new cancers was verified by the patients´ physicians. Patients´ vital status 
was regularly checked through population registries. 
2.2.3.2. Assessment of quality of life 
At 5YFU, QOL was measured using the cancer-specific QOL questionnaire QLQ-C30 
(Aaronson et al., 1993). As mentioned earlier (1.2.2.2), the questionnaire contains five 
functional scales, three symptom scales, a global health and QOL scale (global QOL), and 
six single items. All QLQ-C30 scales were included in the analyses and scoring was 
performed according to the EORTC QLQ-C30 scoring manual (Fayers et al., 2001). All 
scores were linearly transformed to a 0-100 point scale. Higher scores on global QOL and 
functioning scales imply better QOL, whereas higher scores on the symptom scales imply 
worse QOL. Differences of 10 points or more were considered as clinically meaningful 
(Osoba et al., 1998). 
2.2.3.3. Assessment of fatigue 
At 5YFU, fatigue was measured using the FAQ developed by Glaus et al. (Glaus and Muller, 
2001) and the QLQ-C30. The FAQ assesses the dimensions physical, cognitive, and 
affective fatigue. Since in the DACHS study, only the cognitive (3 items) and affective (5 
items) questions of the FAQ were assessed, the fatigue scale of the QLQ-C30 (3 items) 
was included to additionally include the physical aspect of fatigue. Scoring was performed 
according to the FAQ and the QLQ-C30 scoring manuals (Fayers et al., 2001; Glaus and 
Muller, 2001). Cognitive scores were linearly transformed to a 0-9 point scale, affective 
scores to a 0-15 point scale, and physical fatigue to a 0-100 point scale. Lower scores on 
cognitive, affective, and physical fatigue imply less fatigue. 
2.2.3.4. Assessment of physical activity 
At baseline, patients were asked for the hours per week they had engaged in different types 
of PA (hard work, light work, walking, cycling, sports). Information on PA was collected 
retrospectively at age 20, 30, 40, 50, 60, 70, and 80 years. At 5YFU, self-reported 
information on average PA during the last week was collected, using the short-form of the 
IPAQ (Craig et al., 2003). The questionnaire asks for the number of days and minutes per 
week during which different activity types (vigorous PA e.g. jogging; moderate PA e.g. 
swimming; and walking) were performed (see section 1.3.5 for further details). 
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Based on activity-specific MET score values described by Craig et al. (Craig et al. 2003), 
MET hours per week (MET-h/wk) were calculated according to activities performed at 
baseline and at 5YFU (Table 2). 
Table 2 Activity-specific MET-h/wk at baseline and at five-year follow-up 
Baseline Five-year follow up 
Activity MET-h/wk Activity MET-h/wk 
Hard work 8.0 Vigorous 8.0 
Light work 2.5 Moderate 4.0 
Walking 3.3 Walking 3.3 
Cycling 6.0   
Sports 8.0   
MET-h/wk: Metabolic equivalent hours per week 
Based on these values, for baseline PA the MET-h/wk spent at ages 20, 30, 40, 50, 60, 70, 
and 80 and for PA at 5YFU, the MET-h/wk of the last week were calculated for each patient 
and for each of the specific activity types. For baseline PA, information from all age decades 
was used to calculate the activity-specific lifetime MET-h/wk (considering the current age of 
the patient and the years spent in each decade) and information from the age decade 
preceding the patients´ current age was used to calculate the activity-specific MET-h/wk for 
the last age decade. The activity-specific MET-h/wk were summed up to create the variables 
baseline PA (lifetime, last decade) and 5YFU PA. 
For the analyses on QOL and on fatigue, baseline PA was categorized into different PA 
domains (leisure time PA [walking, cycling, sports] and work-related PA [light work, hard 
work]) and intensities (light PA [light work], moderate PA [walking], and vigorous PA [cycling, 
sports, hard work]). Physical activity intensity was classified according to the Physical 
Activity Guidelines for Americans (U.S. Department of Health and Human Services, 2008): 
light-intensity PA= 1.1-2.9 METs, moderate PA= 3-5.9 METs, and vigorous PA= ≥6 METs. 
For all analyses, quartiles for PA at baseline and 5YFU were calculated to differentiate 
between higher and lower levels of PA. Quartiles were calculated based on MET-h/wk. 
Patients in quartile 1 (Q1) were defined as physically inactive whereas patients in quartile 
2 to quartile 4 (Q2-Q4) were defined as physically active. 
Further, for the analyses on QOL and on fatigue these quartiles were used to classify 
participants into four groups: active maintainers (active at baseline and at 5YFU), increasers 
(inactive at baseline, active at 5YFU), decreasers (active at baseline, inactive at 5YFU), and 
inactive maintainers (inactive at baseline and at 5YFU). 
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In the analyses on QOL and on fatigue, PA of the preceding age decade was defined as 
pre-diagnosis PA and PA at 5YFU as post-diagnosis PA to emphasize the timing of 
assessment. In the analysis on determinants of physical inactivity, PA of the preceding age 
decade was defined as baseline PA. 
2.2.4. Statistical analysis 
The statistical software package SAS 9.4 (SAS Institute) was used to perform all data 
analyses. All statistically significant results mentioned in this dissertation refer to a p-
value <0.05 in two-sided testing. For the analyses on QOL and on fatigue complete case 
analyses were performed since the number of missing variables was generally low. Due to 
some modifications during the data quality checks of the updated dataset there were less 
missing values for PA at 5YFU and therefore multiple imputation of missing values was not 
needed. Further, no adjustment for multiple testing was implemented, given the exploratory 
nature of the analysis. For the analysis on determinants of physical inactivity, multiple 
imputation of missing data for covariates and PA at 5YFU was performed with R, version 
3.4.0, using the R package mice, version 2.30 (N = 25 imputed datasets). 
2.2.4.1. Association between physical activity and quality of life 
In descriptive analyses, age-adjusted mean levels of pre- and post-diagnosis PA measured 
in MET-h/wk were calculated according to patient characteristics and compared using linear 
regression models. To estimate the ordinal association between pre- and post-diagnosis 
PA, Kendall rank correlations were calculated. 
Adjusted means with 95% confidence intervals (CI) were computed using multivariable 
linear regression models to explore the association of pre-diagnosis PA quartiles with QOL 
(using the lowest quartile as the reference category). Comprehensive covariate adjustment 
included baseline age, sex, marital status, residential area, education, comorbidities, 
alcohol intake, smoking, body mass index (BMI), cancer site, cancer stage, radiotherapy, 
chemotherapy, and stoma. 
Multivariable linear regression analyses were repeated, calculating beta values (ß) with 
95% CI and modeling pre-diagnosis PA as a continuous variable (per 100 MET-h/wk) for 
different domains (leisure time vs. work-related) and intensities of PA (low vs. moderate vs. 
vigorous) with QOL. In order to assess the independent associations of leisure time and 
work-related as well as light, moderate, and vigorous PA with QOL, these variables were 
jointly included in the analytical model. 
26 2 Material and Methods 
 
Additionally, multivariable linear regression models were calculated to explore the 
association between post-diagnosis PA and QOL, using PA quartiles with the lowest quartile 
as the reference category. Covariate adjustment was conducted in three steps. Firstly 
including the same covariates (updated at 5YFU) as used in the analysis of pre-diagnosis 
PA and QOL, secondly adding pre-diagnosis PA to the model, and finally adding CRC 
recurrence. Since results did not substantially change using the different covariate 
adjustments, only results of the first covariate adjustment are reported. 
Further, multiple linear regression models were repeated for the association between 
changes in PA and QOL, using inactive maintainers as the reference category. Covariate 
adjustment was performed as in the analysis of pre-diagnosis PA and QOL with covariates 
updated at 5YFU. 
2.2.4.2. Association between physical activity and fatigue 
All linear regression analyses as described in section 2.2.4.1 were repeated for the 
association of pre- and post-diagnosis PA with fatigue. Additionally, partial r²-values were 
calculated to assess the independent proportion of the explained variance of fatigue by pre- 
and post-diagnosis PA after adjustment for potential confounders. 
2.2.4.3. Potential determinants of physical inactivity 
In descriptive analyses, the mean levels of PA at 5YFU measured in MET-h/wk were 
calculated according to patient characteristics and compared using the Kruskal-Wallis test. 
Based on previous literature (Courneya et al., 2005; Fisher et al., 2016; Lynch et al., 2010; 
van Putten et al., 2016), patient characteristics considered as potential determinants of 
physical inactivity at 5YFU included socio-demographic characteristics (baseline age, sex, 
marital status, residential area, citizenship, education), tumor-related characteristics 
(cancer site, cancer stage, primary therapy, recurrence, stoma), lifestyle factors (BMI, 
alcohol, smoking, baseline PA), and comorbidities. The following variables were measured 
both at baseline and at 5YFU: stoma, comorbidities, BMI, alcohol, and smoking. 
Odds ratios and 95% CI were calculated using bivariate (unadjusted) and multivariable 
logistic regression to explore the association of baseline and 5YFU characteristics with 
physical inactivity (using the lowest quartile as the reference category). In order to unravel 
the interrelatedness of factors measured both at baseline and follow-up (such as stoma, 
comorbidities, BMI, alcohol, smoking, and PA) as well as the influence of disease 
recurrence on modifiable factors, different model strategies were employed as a starting 
point for variable selection: 
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• Model 1: Baseline variables only (age, sex, marital status, residential area, citizenship, 
education, cancer site, cancer stage, primary therapy, comorbidities, stoma, alcohol, 
smoking, BMI) 
• Model 2: Model 1 plus baseline PA 
• Model 3: Model 1 but baseline information regarding comorbidities, stoma, alcohol, 
smoking, and BMI was replaced by the corresponding information at 5YFU 
• Model 4: Model 3 plus baseline PA 
• Model 5: Model 4 plus recurrence 
In all models, a backward elimination (removing factors with p ≥0.10) was employed to 
restrict each of the respective modeling strategies to the most important factors of physical 
inactivity at 5YFU, while keeping age and sex as permanent covariates. This implies that, 
in each of the models, all covariates which were selected in at least one of the imputed 
datasets were included in the final model. Logistic regression analyses were then performed 
for all models using only these selected variables. 
The Akaike information criterion was used to compare the relative quality of the five different 
modeling strategies by calculating its mean and standard deviation (SD) over all imputed 
datasets per model. 
The selected covariates from model 2 were used for analyses within subgroups according 
to age and sex to gain more insight into PA patterns within each subgroup. Interaction terms 
were added to the model to test for heterogeneity in subgroup analyses. 
 
28 3 Results 
 
3. RESULTS 
3.1. Systematic review of the association between physical activity and 
quality of life in long-term colorectal cancer survivors 
3.1.1. Literature search 
The search identified 988 articles (Figure 1). After removing the duplicates, 740 publications 
remained. After checking titles and abstracts for eligibility, 80 relevant articles were 
identified. Thirty articles were excluded because they were not original articles, and 32 were 
excluded because they did not include long-term CRC survivors. Two articles (Johnson et 
al., 2009; Schlesinger et al., 2014) assessed QOL on only one scale and were therefore 
excluded. One article (Domati et al., 2011) did not report any results regarding the 
association of PA and QOL. One article (Mosher et al., 2009) did not report separate results 
for CRC survivors and four articles (Gunes-Bayir et al., 2015; Hara and Kubo, 2015; Kripp 
et al., 2015; Lonkvist et al., 2013) were excluded for several other reasons. 
In the end, ten articles based on seven studies were included in this systematic review. Two 
articles of Blanchard et al. (Blanchard et al., 2008; Blanchard et al., 2010) were based on 
the same study population (American Cancer Society’s Study of Cancer Survivors-II, SCS-
II). Also the data for the two articles of van Roekel et al. (van Roekel et al., 2015; van Roekel 
et al., 2016) were taken from an identical study population (Energy for life after ColoRectal 
cancer, EnCoRe). Further, all CRC patients diagnosed between 2000 and 2009 as 
registered in the PROFILES cancer registry were selected for the articles of Mols et al. 
(Mols et al., 2015) and Husson et al. (Husson et al., 2015). In case of multiple articles per 
study, each study only counted once but results from all articles are shown in the tables. 
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Figure 1 Flow diagram of the systematic literature search. QOL: quality of life, PA: physical 
activity, CRC: colorectal cancer 
  
 
PubMED 
N = 219 
Web of 
Science 
N = 594 
psychINFO 
N = 98 
CINAHL 
N = 76 
Total: 988 
Titles/abstracts reviewed: 740 
248 duplicate records 
Selected: 80 
660 not relevant 
Original articles: 50 
30 not original article 
32 no long-term survivors 
Included articles: 10 
2 QOL only on one scale 
1 PA outcome not reported 
1 no seperate results CRC 
4 several reasons 
Cross 
referencing 
N = 1 
Included studies: 7 
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3.1.2. Study characteristics 
3.1.2.1. Participants´ characteristics 
Four studies were conducted in the US (Blanchard et al., 2008; Blanchard et al., 2010; 
Blanchard et al., 2004; Rodriguez et al., 2015; Thraen-Borowski et al., 2013), two (Husson 
et al., 2015; Mols et al., 2015; van Roekel et al., 2015; van Roekel et al., 2016) in the 
Netherlands and one in Australia (Chambers et al., 2012b) (Table 3). Sample sizes ranged 
from 86 (Blanchard et al., 2004) to 1918 (Blanchard et al., 2008). All of the included studies 
investigated female and male survivors, but most reported a slightly higher proportion of 
males. The mean age at time of QOL assessment ranged from 68.4 (Husson et al., 2015) 
to 81.5 (Thraen-Borowski et al., 2013) years. Two studies were restricted to long-term 
survivors only (Rodriguez et al., 2015; Thraen-Borowski et al., 2013). All the other studies 
(Blanchard et al., 2008; Blanchard et al., 2010; Blanchard et al., 2004; Chambers et al., 
2012b; Husson et al., 2015; Mols et al., 2015; van Roekel et al., 2015; van Roekel et al., 
2016) did not provide specific results for long-term CRC survivors, but comprised survivors 
with a mean of ≥5 years since diagnosis at the time of QOL assessment. Four studies 
(Blanchard et al., 2008; Blanchard et al., 2010; Blanchard et al., 2004; Husson et al., 2015; 
van Roekel et al., 2015; van Roekel et al., 2016) included CRC survivors from two years 
post-diagnosis, one prospective study (Chambers et al., 2012b) included participants from 
five months post-diagnosis, but the results for the association between PA and QOL was 
based on PA and QOL data collected five years post-diagnosis. Mols et al. (Mols et al., 
2015) included survivors from one year up to eleven years post-diagnosis. 
The majority of the studies (Blanchard et al., 2008; Blanchard et al., 2004; Mols et al., 2015; 
van Roekel et al., 2015; van Roekel et al., 2016) provided information regarding treatment, 
such as proportions of patients undergoing surgery, chemotherapy and radiation. Three 
studies included patients with metastases (Blanchard et al., 2008; Blanchard et al., 2010; 
Blanchard et al., 2004; Husson et al., 2015; Mols et al., 2015), three studies (Chambers et 
al., 2012b; Rodriguez et al., 2015; van Roekel et al., 2015; van Roekel et al., 2016) excluded 
patients with metastases and one study (Thraen-Borowski et al., 2013) did not report cancer 
stage. Four studies (Blanchard et al., 2004; Chambers et al., 2012b; Rodriguez et al., 2015; 
Thraen-Borowski et al., 2013) solely included survivors with a primary diagnosis of CRC, 
and the other studies did not give information about inclusion of survivors with other cancer 
diagnoses. Three studies (Blanchard et al., 2010; Rodriguez et al., 2015; van Roekel et al., 
2015; van Roekel et al., 2016) reported the inclusion of patients with cancer recurrence. 
Regarding cancer site, all studies included patients with colon as well as rectal cancers. 
Five studies (Chambers et al., 2012b; Husson et al., 2015; Mols et al., 2015; Rodriguez et 
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al., 2015; Thraen-Borowski et al., 2013; van Roekel et al., 2015; van Roekel et al., 2016) 
included solely patients with CRC, whilst two studies (Blanchard et al., 2008; Blanchard et 
al., 2010; Blanchard et al., 2004) also included patients with other cancer types. However, 
the results regarding the association between PA and QOL as well as all figures shown in 
Table 3 are CRC-specific, only response rates are reported for all cancer types together 
(Blanchard et al., 2008; Blanchard et al., 2010; Blanchard et al., 2004).
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Table 3 Characteristics of the studies included in the review 
First author  
(year) 
country 
Study design Sample 
size 
Age at survey Time since 
diagnosisa 
Cancer treatment Cancer 
stage 
PA 
instrument 
QOL 
instrument 
Meeting PA 
recommendations 
Blanchard  
(2004) 
USA 
 
Cross-sectional, 
population-based 
86 Mean (SD) 
69.22 (12.5) 
≥2 years 33.7% 
≥5 years 30.2% 
≥10 years 36.0% 
Surgery 
Radiation 
Chemotherapy 
 
I-IV Adherence 
to PA 
recommen-
dations 
 
SF-36 69.8% 
Blanchard 
(2008)b 
USA 
 
Cross-sectional,  
population-based 
1918 Mean (SD)  
70.2 (11.0) 
≥2 years 33.4% 
≥5 years 35.3% 
≥10 years 31.3% 
Surgery 
Radiation  
Chemotherapy 
Hormone therapy 
Immuno therapy 
BMT 
 
I-IV GLTEQ SF-36 35%  
Blanchard 
(2010)b 
USA 
 
Cross-sectional,  
population-based 
668 Mean (SD) 
70.2 (11.1) 
≥2 years 26.8% 
≥5 years 40.5% 
≥10 years 32.0% 
 
In treatment (not 
further specified) 
I-IV  GLTEQ SF-36 HW 20.0% 
OW 30.0% 
OB 24.4% 
 
Chambers 
(2012) 
Australia 
 
Cross-sectional & 
longitudinal,  
population-based 
632 Mean 
69.02 
≥5 years  
Mean (SD) 
5 (6.1) 
 
Surgery 
Chemotherapy 
I-III AAS FACT-C 
SWLS  
‒ 
Husson 
(2015)c 
The Netherlands 
 
Cross-sectional & 
longitudinal,  
population-based 
1739 Mean (SD) 
68.4 (9.4) 
≥2 years 
Mean (SD) 
5.1 (2.8) 
 
Radiation  
Chemotherapy 
I-IV EPIC QLQ-C30 82%  
Mols 
(2015)c 
The Netherlands 
 
Cross-sectional,  
population-based 
1648 Mean (SD)  
Chemotherapy:  
66.7 (9.8) 
No chemotherapy: 
70.6 (9.0) 
1-11 years 
Mean (SD)  
Chemotherapy:  
5.6 (2.8) 
No chemotherapy: 
6.1 (2.8) 
 
Surgery 
Radiation 
I-IV EPIC QLQ-C30 
QLQ-
CIPN20 
Chemotherapy: 
93%  
No Chemotherapy: 
89% 
Rodriguez 
(2015) 
USA 
Cross-sectional,  
population-based 
593 Mean  
73.8 
Only ≥5 years 
Mean  
6.2 
 
Number of 
treatments 
I-III GLTEQ PROMIS 
EQ-5D 
‒ 
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 Table 3 Characteristics of the studies included in the review (continued)     
First author 
(year) 
country 
Study design Sample 
size 
Age at survey Time since 
diagnosisa 
Cancer treatment Cancer 
stage 
PA 
instrument 
QOL 
instrument 
Meeting PA 
recommendations 
Thraen-Borowski 
(2013) 
USA 
 
Cross-sectional,  
population-based 
832 Mean (SD)  
81.5 (5.8) 
Only ≥5 years 
Mean (SD)  
8.2 (1.7) 
- - CHAMPS SF-36 52% 
Van Roekel 
(2015)d 
The Netherlands 
Cross-sectional, 
mono-centric 
151 Mean (SD)  
69.8 (8.7) 
2-10 years 
Mean (SD)  
5.7 (1.8) 
Surgery 
Radiation 
Chemotherapy 
I-III 
 
SQUASH QLQ-C30 
WHODAS II 
CIS 
HADS 
 
71% 
Van Roekel 
(2016)d 
The Netherlands 
Cross-sectional, 
mono-centric 
145 Mean (SD)  
70.0 (8.7) 
2-10 years 
Mean (SD) 
5.7 (1.9) 
Surgery 
Radiation 
Chemotherapy 
I-III MMOXX1 QLQ-C30 
WHODAS II 
CIS 
HADS 
 
‒ 
PA: physical activity; QOL: quality of life; PA recommendations: 150 minutes of moderate intensity exercise each week or 75 minutes of vigorous intensity activity each week or an equivalent combination 
of both; SD: standard deviation; SF-36: The Short Form Health Survey; BMT: Bone marrow transplantation; GLTEQ: Godin Leisure-Time Exercise Questionnaire; HW: healthy weight; OW: overweight; 
OB: obese; AAS: The Active Australian Survey; FACT-C: Functional Assessment of Cancer Therapy - Colorectal Cancer; SWLS: Satisfaction With Life Scale; EPIC: European Prospective Investigation 
into Cancer Physical Activity Questionnaire; QLQ-C30: Quality of Life Questionnaire-Core 30; QLQ-CIPN20: Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy; PROMIS: 
Patient-Reported Outcomes Measurement Information System; EQ-5D: EuroQol five dimensions questionnaire; CHAMPS: The Community Healthy Activities Model Program for Seniors; SQUASH: The 
Short Questionnaire to Assess Health-Enhancing Physical Activity; WHODAS: World Health Organization Disability Assessment Schedule; CIS: Checklist Individual Strength; HADS: Hospital Anxiety 
and Depression Scale; MMOXX1: Triaxial MOX activity monitor; aTime since diagnosis at time point of QOL assessment; bArticles based on same study population: American Cancer Society´s Study of 
Cancer Survivors-II (SCS-II); cArticles based on same study population: All patients diagnosed between 2000-2009 and registered in the Patient Reported Outcomes Following Initial treatment and Long 
term Evaluation of Survivorship (PROFILES registry); dArticles based on same study population: Energy for life after ColoRectal cancer (EnCoRe) 
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3.1.2.2. Study design 
All included studies were observational in design. Recruitment methods varied across 
studies, six (Blanchard et al., 2008; Blanchard et al., 2010; Blanchard et al., 2004; 
Chambers et al., 2012b; Husson et al., 2015; Mols et al., 2015; Rodriguez et al., 2015; 
Thraen-Borowski et al., 2013) used population-based recruitment, and one (van Roekel et 
al., 2015; van Roekel et al., 2016) was completed in a single institution. Two of the articles 
(Chambers et al., 2012b; Husson et al., 2015) were prospective, longitudinal designs 
assessing PA and/or QOL at multiple points in time, while the remaining eight were cross-
sectional (Blanchard et al., 2008; Blanchard et al., 2010; Blanchard et al., 2004; Mols et al., 
2015; Rodriguez et al., 2015; Thraen-Borowski et al., 2013; van Roekel et al., 2015; van 
Roekel et al., 2016). 
3.1.2.3. Response rate and follow-up rate 
The response rates in the aforementioned cross-sectional studies ranged from 33% 
(Blanchard et al., 2008) (not CRC-specific) to 83% (Mols et al., 2015). Husson et al. (Husson 
et al., 2015) reported a participation of 73% at baseline, 83% for the first and 82% for the 
second follow-up. In the study of Chambers et al. (Chambers et al., 2012b) 56% of the 
survivors participated in the follow-up, however no information was given regarding baseline 
participation. 
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3.1.2.4. Quality assessment 
The results of the quality assessment of the included studies are displayed in Table 4. 
Table 4 Quality assessment of the studies included in the review 
First author (year) 
country 
 Potential Limitations 
Blanchard (2004) 
USA 
 - No validated PA questionnaire used 
- Possible response bias due to self-reported PA 
- Sample size <100 
- Cross-sectional study design 
   
Blanchard (2008)a 
USA 
 - Possible response bias due to self-reported PA 
- Only assessment of leisure-time PA 
- Cross-sectional study design 
 
   
Blanchard (2010)a 
USA 
 - Possible response bias due to self-reported PA 
- Only assessment of leisure-time PA 
- Cross-sectional study design 
 
   
Chambers (2012) 
Australia 
 - Possible response bias due to self-reported PA 
- Only assessment of leisure-time PA 
 
 
   
Husson (2015)b 
The Netherlands 
 - Possible response bias due to self-reported PA 
 
 
 
   
Mols (2015)b 
The Netherlands 
 - Possible response bias due to self-reported PA 
- Cross-sectional study design 
 
 
   
Rodriguez (2015) 
USA 
 - Possible response bias due to self-reported PA 
- Cross-sectional study design 
 
 
   
Thraen-Borowski (2013) 
USA 
 - Possible response bias due to self-reported PA 
- Only assessment of leisure-time PA 
- Cross-sectional study design 
 
   
Van Roekel (2015)c 
The Netherlands 
 - Possible response bias due to self-reported PA 
- Cross-sectional study design 
 
 
   
Van Roekel (2016)c 
The Netherlands 
 - Cross-sectional study design 
 
 
 
   
PA: physical activity; aArticles based on same study population: American Cancer Society´s Study of Cancer Survivors-II 
(SCS-II); bArticles based on same study population: All patients diagnosed between 2000-2009 and registered in the Patient 
Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship (PROFILES registry); cArticles based 
on same study population: Energy for life after ColoRectal cancer (EnCoRe) 
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3.1.2.5. Assessment and categorization of physical activity 
Apart from one article which measured PA prospectively at three points in time (Husson et 
al., 2015), all other articles (Blanchard et al., 2008; Blanchard et al., 2010; Blanchard et al., 
2004; Chambers et al., 2012b; Mols et al., 2015; Rodriguez et al., 2015; Thraen-Borowski 
et al., 2013; van Roekel et al., 2015; van Roekel et al., 2016) assessed PA only once. One 
article (van Roekel et al., 2016) measured PA by using the Triaxial MOX activity monitor 
(MMOXX1). The MMOXX1 is able to objectively measure sedentary, standing and PA time. 
Apart from Blanchard et al. (Blanchard et al., 2004) who only reported the adherence or 
non-adherence to PA recommendations, all other studies (Blanchard et al., 2008; Blanchard 
et al., 2010; Chambers et al., 2012b; Husson et al., 2015; Mols et al., 2015; Rodriguez et 
al., 2015; Thraen-Borowski et al., 2013; van Roekel et al., 2015) used validated PA 
instruments relying on self-report. The questionnaire most frequently applied was the 
GLTEQ. Several studies (Blanchard et al., 2008; Blanchard et al., 2010; Blanchard et al., 
2004; Husson et al., 2015; Mols et al., 2015; Thraen-Borowski et al., 2013) used PA 
recommendations such as the one published by the ACS to differentiate between active 
and non-active survivors. The ACS recommends at least 150 min of moderate intensity 
exercise each week or 75 min of vigorous intensity activity each week or an equivalent 
combination of both (Kushi et al., 2012). To further quantify the intensity of PAs, MET-h/wk 
were used in five articles (Husson et al., 2015; Mols et al., 2015; Thraen-Borowski et al., 
2013; van Roekel et al., 2015; van Roekel et al., 2016). In four of these articles light PA was 
defined as <3 MET-h/wk, whereas moderate to vigorous PA was defined as an intensity of 
≥3 MET-h/wk (Husson et al., 2015; Mols et al., 2015; Thraen-Borowski et al., 2013; van 
Roekel et al., 2015). One article (van Roekel et al., 2016) defined PA as >1.5 MET-h/day 
and did not further differentiate between light PA and moderate to vigorous PA. 
3.1.2.6. Assessment of quality of life 
Quality of life was assessed only at one point in time in most of the studies (Blanchard et 
al., 2008; Blanchard et al., 2010; Blanchard et al., 2004; Mols et al., 2015; Rodriguez et al., 
2015; Thraen-Borowski et al., 2013; van Roekel et al., 2015; van Roekel et al., 2016). Only 
the two longitudinal studies (Chambers et al., 2012b; Husson et al., 2015) assessed QOL 
at different intervals. Chambers et al. assessed QOL five months post-diagnosis and five 
years after diagnosis (Chambers et al., 2012b). Husson et al. assessed QOL in yearly 
intervals over a three year period, starting with a baseline average time since diagnosis of 
5.1 years (Husson et al., 2015). The QOL questionnaires most commonly used were the 
QLQ-C30 (Husson et al., 2015; Mols et al., 2015; van Roekel et al., 2015; van Roekel et al., 
2016) and the SF-36 (Blanchard et al., 2008; Blanchard et al., 2010; Blanchard et al., 2004). 
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Information was collected by mail in six studies (Blanchard et al., 2008; Blanchard et al., 
2010; Blanchard et al., 2004; Husson et al., 2015; Mols et al., 2015; Rodriguez et al., 2015; 
Thraen-Borowski et al., 2013; van Roekel et al., 2015), by telephone in five studies 
(Blanchard et al., 2008; Blanchard et al., 2010; Blanchard et al., 2004; Chambers et al., 
2012b; Rodriguez et al., 2015; Thraen-Borowski et al., 2013), and in person in one study 
(van Roekel et al., 2016). One study (van Roekel et al., 2015; van Roekel et al., 2016) 
assessed only some of the QLQ-C30 subscales and additionally used the Hospital Anxiety 
and Depression Scale (HADS), the Checklist Individual Strength (CIS), and the World 
Health Organization Disability Assessment Schedule (WHODAS) questionnaire to assess 
QOL in CRC survivors. 
3.1.3. Analysis, statistical methods, and clinical relevance 
All studies compared CRC survivors who were active with those who were less active or 
not active. Most of the studies compared survivors who met PA recommendations to those 
survivors who did not (Blanchard et al., 2008; Blanchard et al., 2010; Blanchard et al., 2004; 
Husson et al., 2015; Mols et al., 2015; Thraen-Borowski et al., 2013). Two studies compared 
different amounts of activity to a non-active reference group of CRC survivors (Chambers 
et al., 2012b; Rodriguez et al., 2015). Some studies compared survivors  ́QOL according to 
higher and lower levels of light PA (Thraen-Borowski et al., 2013; van Roekel et al., 2015) 
and/or moderate to vigorous PA (Husson et al., 2015; Rodriguez et al., 2015; Thraen-
Borowski et al., 2013; van Roekel et al., 2015). One study additionally compared lower with 
higher amounts of non-exercise (e.g. gardening) and planned exercise (PA that is planned, 
structured and repetitive e.g. jogging) (Thraen-Borowski et al., 2013). 
All studies examined possible confounding factors including age, sex, and comorbidities by 
some sort of multivariable regression modeling or analysis of (co)variance. Six studies 
adjusted for BMI and only three for smoking. Three studies performed stratified analyses by 
age, sex, comorbidities, treatment, and BMI for the association between PA and QOL. 
One study (Husson et al., 2015; Mols et al., 2015) reported clinical relevance for the QLQ-
C30. One study reported an overall clinical relevance for the SF-36 of 5-10 score points 
mean difference (Thraen-Borowski et al., 2013). For some studies (Blanchard et al., 2008; 
Blanchard et al., 2010; Blanchard et al., 2004; Chambers et al., 2012b) the clinical relevance 
was not reported and could not be derived from the available information. Moreover, two 
studies used SDs to determine clinical relevance (Mols et al., 2015; van Roekel et al., 2016). 
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3.1.4. Study findings regarding the association between physical activity and 
quality of life 
According to the included studies, 35-80% of the CRC survivors met the PA 
recommendations (Table 3). Table 5, Table 6, Table 7, and Appendix II show the study 
specific results regarding the association between PA and QOL according to type of 
analysis and type of QOL instrument. Since the included studies used various QOL 
questionnaires, which differ in the included scales, not all studies contributed to the results 
on every outcome and are thus not considered when summarizing the respective findings. 
3.1.4.1. Physically active versus not active 
Five of the six studies which compared active with non-active CRC survivors, found positive 
associations between PA and QOL (Table 5). Regarding specific subscales, homogenous 
results were found for global QOL, which was positively associated with PA in all of the five 
studies which investigated global QOL. Differences in global QOL between physically active 
versus non-active survivors were clinically relevant in two (Husson et al., 2015; Thraen-
Borowski et al., 2013) of the five studies. Three out of four studies reported a positive 
association between PA and physical functioning, of these two (Husson et al., 2015; 
Thraen-Borowski et al., 2013) associations were of clinical relevance. Two studies 
(Blanchard et al., 2008; Blanchard et al., 2004) did not report any results on physical 
functioning. In contrast, results for role and social functioning were more heterogeneous 
and less often statistically significant. 
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 Table 5 Association of physical activity and quality of life - active vs. not active 
 
Statistical significance (p<0.05) and clinical relevance 
+/–: significant positive/negative association 
ns: not statistically significant 
.: not reported 
a,b,cclinical relevance 
Study QLQ-C30 QL PF RF EF SF CF 
Husson 
(2015) 
Meeting vs. not meeting PA  
recommendations, Interindividuald +b +b +b +b +b + 
 Meeting vs. not meeting PA  
recommendations, Intraindividuale + + + ns ns ns 
Mols 
(2015) 
Meeting vs. not meeting PA  
recommendations +c +c +c +c +c +c 
Study SF-36 PF RP BP SF MH RE VT GH GCS PCS MCS 
Blanchard 
(2004) 
Meeting vs. not meeting PA  
recommendations . . . . . . . . +c . . 
Blanchard  
(2008) 
Meeting vs. not meeting PA  
recommendations . . . . . . . . +c . . 
Thraen-Borowski 
(2013) 
Meeting vs. not meeting PA  
recommendations +a +a + +a ns ns +a +a . . . 
Study FACT-C/ SWLS PWB SWB EWB FWB CCS SWLS 
Chambers 
(2012) 
Sedentary - Ref. 
Insufficiently active (1-149 min/wk) ns ns ns ns ns ns 
 Sufficiently active (≥150 min/wk) ns ns ns ns ns ns 
Study PROMIS/ EQ-5D Physical HRQOL Mental HRQOL Overall HRQOL 
Rodriguez 
(2015) 
PA min/wk 
No PA - Ref. 
≤60, 61-149, 150-249, 250+ +c (≤ 60, 61-149, 150-249) ns +c (≤ 60, 61-149, 150-249) 
QOL: quality of life; QLQ-C30 (Quality of Life Questionnaire-Core 30) QL: global QOL, PF: physical functioning, RF: role functioning, EF: emotional functioning, SF: social functioning, CF: cognitive 
functioning; PA: physical activity; PA recommendations: 150 minutes of moderate intensity exercise each week or 75 minutes of vigorous intensity activity each week or an equivalent combination of 
both; SF-36 (The Short Form Health Survey) PF: physical functioning, RP: role limitations due to physical health problems, BP: bodily pain, SF: social functioning, MH: general mental health, RE: role 
limitations due to emotional problems, VT: vitality, GH: general health perceptions, GCS: global health composite score, PCS: physical composite score, MCS: mental composite score; FACT-C (Functional 
Assessment of Cancer Therapy - Colorectal Cancer) PWB: physical well-being, SWB: social well-being, EWB: emotional well-being, FWB: functional well-being, CCS: colorectal cancer scale; SWLS 
(Satisfaction with Life Scale); Ref.: reference; min/wk: minutes per week; PROMIS (Patient-Reported Outcomes Measurement Information System); EQ-5D (EuroQol five dimensions questionnaire); 
HRQOL: health-related QOL; aclinical relevance reported by authors; bclinical relevance calculated by RE; cclinical relevance: no values, no cut-off for calculation available; dinterindividual: patients 
average amount of PA/ average level PA of total group; eintraindividual: patients PA level at one time point/ patients average PA level 
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3.1.4.2. Different intensities of physical activity and linear association of 
physical activity and quality of life 
Table 6 shows the results from the studies examining the association between multiple 
intensities of PA and QOL. Higher QOL was associated with both, lower and higher PA 
intensities but the association between PA and QOL depended on the specific QOL 
dimension. For instance, survivors who had higher levels of light PA reported significantly 
and clinically relevant higher physical functioning than survivors who had lower light PA 
levels (Thraen-Borowski et al., 2013; van Roekel et al., 2015), but no association was found 
between global QOL, social functioning, and light PA (van Roekel et al., 2015), respectively. 
Positive associations between moderate to vigorous PA and physical functioning were 
found in two (Thraen-Borowski et al., 2013; van Roekel et al., 2015) of three (Rodriguez et 
al., 2015; Thraen-Borowski et al., 2013; van Roekel et al., 2015) studies. Survivors who 
reported higher moderate to vigorous PA reported significantly and clinically relevant higher 
physical functioning compared to survivors who had lower moderate to vigorous PA 
(Thraen-Borowski et al., 2013; van Roekel et al., 2015). 
When assessing PA as a continuous variable, significant positive associations of moderate 
to vigorous PA with higher global QOL, physical, emotional, social, and cognitive functioning 
were found (Husson et al., 2015). Van Roekel et al. reported significant positive 
associations between PA time (hour/day) and physical functioning and disability, however, 
no associations were found for global QOL, role and social functioning, fatigue, anxiety, and 
depression (van Roekel et al., 2016). 
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 Table 6 Association of physical activity and quality of life - different intensities of physical activity and linear association 
 Statistical significance (p<0.05) and clinical relevance  
Different intensities of PA 
+/–: significant positive/negative association 
ns: not statistically significant 
.: not reported 
a,b,cclinical relevance  
Study QLQ-C30 QL PF RF EF SF CF 
Van Roekel 
(2015) 
>LPA (Q4= ≥23.0 h/wk) vs. 
<LPA (Q1= ≤2.0 h/wk) ns +b +b . ns . 
>LPA (Q3= 10-22 h/wk) vs. 
<LPA (Q1= ≤2.0 h/wk) . . . . . . 
 >MVPA (Q4= ≥15.5 h/wk) vs. 
<MVPA (Q1= ≤4.3 h/wk) ns +b ns . ns . 
 >MVPA (Q3= 8.7-15 h/wk) vs. 
<MVPA (Q1= ≤4.3 h/wk) ns . +b . +b . 
Study SF-36 PF RP BP SF MH RE VT GH GCS PCS MCS 
Thraen- 
Borowski 
(2013) 
>MVPA (Q4= ≥11.25 h/wk) vs. 
<MVPA (Q1= 0.00 h/wk) . . . . . . . . . +b ns 
>LPA (Q4= ≥13.0 h/wk) vs. 
<LPA (Q1= ≤1.50 h/wk)d . . . . . . . . . ns ns 
 >LPA (Q4= ≥9.0 h/wk) vs. 
<LPA (Q1= 0.0 h/wk)e  . . . . . . . . . +b +b 
 >Planned exercisef (Q4= ≥9.50 h/wk) vs. 
<Planned exercise (Q1= 0.0 h/wk) . . . . . . . . . +b ns 
 >Non-exerciseg (Q4= ≥16.50 h/wk) vs.  
<Non-exercise (Q1= ≤1.63 h/wk) . . . . . . . . . + ns 
Study WHODAS/ CIS/ HADS DIS FA DIST 
Van Roekel  
(2015) 
>LPA (Q4= ≥23.0 h/wk) vs. 
<LPA (Q1= ≤2.0 h/wk) –c ns ns 
>LPA (Q3= 10-22 h/wk) vs. 
<LPA (Q1= ≤2.0 h/wk) ns –c ns 
 >MVPA (Q4= ≥15.5 h/wk) vs. 
<MVPA (Q1= ≤4.3 h/wk) ns ns ns 
 >MVPA (Q3= 8.7-15 h/wk) vs. 
<MVPA (Q1= ≤4.3 h/wk) –c –c –c 
Study PROMIS/ EQ-5D Physical HRQOL Mental HRQOL Overall HRQOL 
Rodriguez 
(2015) 
MVPA min/wk 
No MVPA - Ref. 
≤60, 61-149, 150+ ns ns 
+c (61-149, 150+) 
ns (≤ 60) 
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Table 6 Association of physical activity and quality of life - different intensities of physical activity and linear association (continued) 
 
  Statistical significance (p<0.05) and clinical relevance 
 Linear association PA and QOL  
(continuous results) 
+/–: significant positive/negative association 
ns: not statistically significant 
.: not reported 
a,b,cclinical relevance  
Study  QLQ-C30 QL PF RF EF SF CF 
Husson 
(2015) 
Continuous: Additional hour of MVPA/wk, 
Interindividualh + + + + + + 
 Continuous: Additional hour of MVPA/wk, 
Intraindividuali ns + ns ns ns + 
Van Roekel 
(2016) 
Single-variable model, PAj ns + ns . ns . 
Partition model, PAk ns + ns . ns . 
Substituting 1 h/day of sedentary time with PA ns +a ns . ns . 
 Substituting 1 h/day of standing time with PA ns ns ns . ns . 
Study WHODAS/ CIS/ HADS DIS FA ANX DEP 
Van Roekel 
(2016) 
Single-variable model PAj –c ns ns ns 
Partition model PAk ns ns ns ns 
Substituting 1 h/day of sedentary time with PA ns ns ns ns 
 Substituting 1 h/day of standing time with PA ns ns ns ns 
PA: physical activity; QOL: quality of life; QLQ-C30 (Quality of Life Questionnaire-Core 30) QL: global quality of life, PF: physical functioning, RF: role functioning, EF: emotional functioning, SF: social 
functioning, CF: cognitive functioning; LPA: light physical activity (<3 metabolic equivalent values [METs]); Q: quartile; h/wk: hours per week; MVPA: moderate to vigorous physical activity (≥3 METs); 
SF-36 (The Short Form Health Survey) PF: physical functioning, RP: role limitations due to physical health problems, BP: bodily pain, SF: social functioning, MH: general mental health, RE: role limitations 
due to emotional problems, VT: vitality, GH: general health perceptions, GCS: global health composite score, PCS: physical composite score, MCS: mental composite score; WHODAS (World Health 
Organization Disability Assessment Schedule II) DIS: disability; CIS (Checklist Individual Strength) FA: fatigue; HADS (Hospital Anxiety and Depression Scale) DIST: distress, ANX: anxiety, DEP: 
depression; PROMIS (Patient-Reported Outcomes Measurement Information System); EQ-5D (EuroQol five dimensions questionnaire); HRQOL: health-related QOL; Ref.: reference; aclinical relevance 
reported by authors; bclinical relevance calculated by RE; cclinical relevance: no values, no cut-off for calculation available; dparticipants reported LPA and MVPA; eparticipants reported only LPA; 
fintentional exercise e.g. jogging, gnon-intentional exercise e.g. gardening; hinterindividual: patients average amount of PA/ average level PA of total group; iintraindividual: patients PA level at one time 
point/ patients average PA level; jPA was entered separately in a single confounder-adjusted model, without adjustment for any of the other activities (sedentary, standing); kall activity categories 
(sedentary, standing, PA) were entered simultaneously in a single confounder-adjusted model, to estimate independent associations of each activity category 
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3.1.4.3. Further subgroup analyses and changes in the association of 
physical activity and quality of life over time 
Only the study by van Roekel et al. provided results stratified by age (van Roekel et al., 
2016) and sex (van Roekel et al., 2015; van Roekel et al., 2016) (Table 7). The association 
between PA and QOL did not differ between younger and older survivors. However, the 
association between light PA/PA and QOL seemed to be stronger among women than 
among men. Women who had higher light PA levels reported significantly and clinically 
relevant higher physical, role, and social functioning and significantly less disability 
compared to women who had lower light PA levels. The association of PA with global QOL, 
fatigue, and distress was not statistically significant. When substituting one hour of 
sedentary time with PA, PA was clinically and significantly associated with higher physical 
functioning and lower disability in women. However, PA was not associated with global 
QOL, role and social functioning, fatigue, anxiety, and depression when substituting one 
hour of sedentary time with PA. In both investigations no significant associations were found 
in men. 
Van Roekel et al. (van Roekel et al., 2015; van Roekel et al., 2016) reported heterogeneous 
results for the association between light PA/PA and QOL stratified by number of 
comorbidities. Survivors with ≥2 comorbidities who reported higher levels of light PA 
reported significantly and clinically relevant higher physical and role functioning and 
significantly less disability than survivors with lower levels of light PA. No associations were 
observed between higher levels of light PA and global QOL, social functioning, fatigue, and 
distress. No associations were reported for light PA levels and any QOL scales for survivors 
with <2 comorbidities (van Roekel et al., 2015). In contrast, when using sedentary time or 
standing time as a proxy measures of (lack of) PA, none of the QOL scales were associated 
with PA in neither survivors with <2 nor survivors ≥2 comorbidities (van Roekel et al., 2016). 
Heterogeneous results were also reported regarding the association between PA and QOL 
with respect to BMI. According to van Roekel et al. (van Roekel et al., 2016) non-obese 
survivors who were physically active reported higher global QOL, lower depression and 
anxiety than less active non-obese survivors. No association between PA and QOL was 
found among obese survivors. In contrast, in the study of Blanchard et al. (Blanchard et al., 
2010) no associations between PA and QOL were found according to BMI. 
Survivors without chemotherapy treatment who were physically active scored significantly 
lower on the sensory, motor, and autonomic scale of the Quality of Life Questionnaire - 
Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) of the EORTC, compared to 
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non-active survivors (Mols et al., 2015). The association between PA and QOL among CRC 
survivors with chemotherapy treatment did not substantially differ, only no significant 
associations were found for PA and the autonomic scale. In both, survivors with and without 
chemotherapy treatment, associations between PA and the motor scale were of clinical 
relevance. 
Only one study assessed PA and QOL at various points in time among the same patients 
(Husson et al., 2015). In CRC survivors who were physically active over a three years 
period, role and social functioning improved whereas role and social functioning declined in 
non-active survivors. No associations were found between persistent PA and global QOL, 
physical, emotional, and cognitive functioning (Husson et al., 2015). 
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 Table 7 Association of physical activity and quality of life - subgroup analyses 
 
 Statistical significance (p<0.05) and clinical relevance  
Subgroup analyses 
+/–: significant positive/negative association  
ns: not statistically significant 
.: not reported 
a,b,cclinical relevance  
Study QLQ-C30 QL PF RF EF SF CF 
 Sex       
Van Roekel 
(2015) 
>LPA (Q4= ≥23.0 h/wk) vs. <LPA (Q1= ≤2.0 h/wk) 
Women ns +b +b . +b . 
Men ns ns ns . ns . 
 Comorbidities       
 >LPA (Q4= ≥23.0 h/wk) vs. <LPA (Q1= ≤2.0 h/wk) 
≥2 comorbidities ns +b +b . ns . 
 <2 comorbidities ns ns ns . ns . 
 Sex       
Van Roekel 
(2016) 
Substituting 1 h/day of sedentary time with PA 
Women ns +a ns . ns . 
Men  ns ns ns . ns . 
 Substituting 1 h/day of standing time with PA 
Women ns ns ns . ns . 
 Men ns ns ns . ns . 
 Age       
 Substituting 1 h/day of sedentary time with PA 
<70 years ns ns ns . ns . 
 ≥70 years ns ns ns . ns . 
 Substituting 1 h/day of standing time with PA 
<70 years ns ns ns . ns . 
 ≥70 years ns ns ns . ns . 
 BMI       
 Substituting 1 h/day of sedentary time with PA 
Non-obese +a ns ns . ns . 
 Obese ns ns ns . ns . 
 Substituting 1 h/day of standing time with PA 
Non-obese ns ns ns . ns . 
 Obese ns ns ns . ns . 
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Table 7 Association of physical activity and quality of life - subgroup analyses (continued) 
 
  Statistical significance (p<0.05) and clinical relevance 
 
Subgroup analyses 
+/–: significant positive/negative association  
ns: not statistically significant 
.: not reported 
a,b,cclinical relevance 
Study QLQ-C30 QL PF RF EF SF CF 
 Comorbidities       
Van Roekel 
(2016) 
Substituting 1 h/day of sedentary time with PA 
<2 comorbidities ns ns ns . ns . 
 ≥2 comorbidities ns ns ns . ns . 
 Substituting 1 h/day of standing time with PA 
<2 comorbidities ns ns ns . ns . 
 ≥2 comorbidities ns ns ns . ns . 
 QLQ-CIPN20 Sensory Motor Autonomic 
 Treatment    
Mols 
(2015) 
Meeting vs. not meeting PA recommendations 
CT, PA vs. CT, no PA + + ns 
 Meeting vs. not meeting PA recommendations 
No CT, PA vs. no CT, no PA +a + + 
 SF-36 PF RP BP SF MH RE VT GH GCS PCS MCS 
 BMI            
Blanchard 
(2010) 
Meeting vs. not meeting PA recommendations  
Healthy weight . . . . . . . . . ns ns 
Overweight . . . . . . . . . ns ns 
 WHODAS/ CIS/ HADS DIS FA DIST 
 Sex    
Van Roekel 
(2015) 
>LPA (Q4= ≥23.0 h/wk) vs. <LPA (Q1= ≤2.0 h/wk) 
Women –c ns ns 
Men ns ns ns 
 Comorbidities    
 >LPA (Q4= ≥23.0 h/wk) vs. <LPA (Q1= ≤2.0 h/wk) 
≥2 comorbidities –c ns ns 
 <2 comorbidities ns ns ns 
     
     
     
 
3
 
R
e
s
u
lts
 
4
7
 
 Table 7 Association of physical activity and quality of life - subgroup analyses (continued) 
 
  Statistical significance (p<0.05) and clinical relevance 
 
Subgroup analyses 
+/–: significant positive/negative association  
ns: not statistically significant 
.: not reported 
a,b,cclinical relevance 
Study WHODAS/ CIS/ HADS DIS FA ANX DEP 
 Sex     
Van Roekel 
(2016) 
Substituting 1 h/day of sedentary time with PA  
Women –a ns ns ns 
Men  ns ns ns ns 
 Substituting 1 h/day of standing time with PA 
Women ns ns ns ns 
 Men  ns ns ns ns 
 Age     
 Substituting 1 h/day of sedentary time with PA  
<70 years ns ns ns ns 
 ≥70 years ns ns ns ns 
 Substituting 1 h/day of standing time with PA  
>70 years ns ns ns ns 
 ≥70 years ns ns ns ns 
 BMI     
 Substituting 1 h/day of sedentary time with PA  
Non-obese ns ns – – 
 Obese ns ns ns ns 
 Substituting 1 h/day of standing time with PA  
Non-obese  ns ns –a – 
 Obese ns ns ns ns 
      
      
      
      
      
      
      
      
 
4
8
  
3
   R
e
s
u
lts
 
 4
8
  
3
   R
e
s
u
lts
 
 4
8
  
3
   R
e
s
u
lts
 
 4
8
  
3
   R
e
s
u
lts
 
 4
8
  
3
   R
e
s
u
lts
 
 4
8
  
3
   R
e
s
u
lts
 
 
Table 7 Association of physical activity and quality of life - subgroup analyses (continued) 
 
  Statistical significance (p<0.05) and clinical relevance 
 
Subgroup analyses 
+/–: significant positive/negative association  
ns: not statistically significant 
.: not reported 
a,b,cclinical relevance 
Study WHODAS/ CIS/ HADS DIS FA ANX DEP 
 Comorbidities     
Van Roekel 
(2016) 
Substituting 1 h/day of sedentary time with PA  
<2 comorbidities ns ns ns ns 
 ≥2 comorbidities ns ns ns ns 
 Substituting 1 h/day of standing time with PA 
<2 comorbidities  ns ns ns ns 
 ≥2 comorbidities ns ns ns ns 
QOL: quality of life; QLQ-C30 (Quality of Life Questionnaire-Core 30) QL: global quality of life, PF: physical functioning, RF: role functioning, EF: emotional functioning, SF: social functioning, CF: cognitive 
functioning; LPA: light physical activity (<3 metabolic equivalent values); Q: quartile; h/wk: hours per week; h/day: hours per day; PA: physical activity; BMI: body mass index; QLQ-CIPN20 (Quality of 
Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy); PA recommendations: 150 minutes of moderate intensity exercise each week or 75 minutes of vigorous intensity activity each week 
or an equivalent combination of both; CT: chemotherapy; SF-36 (The Short Form Health Survey) PF: physical functioning, RP: role limitations due to physical health problems, BP: bodily pain, SF: social 
functioning, MH: general mental health, RE: role limitations due to emotional problems, VT: vitality, GH: general health perceptions, GCS: global health composite score, PCS: physical composite score, 
MCS: mental composite score; WHODAS (World Health Organization Disability Assessment Schedule II) DIS: disability; CIS (Checklist Individual Strength) FA: fatigue; HADS (Hospital Anxiety and 
Depression Scale) DIST: distress, ANX: anxiety, DEP: depression; aclinical importance reported by authors; bcalculated by RE; cno values, no cut-off for calculation available 
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3.2. Results from the DACHS study 
3.2.1. Association between physical activity and quality of life 
3.2.1.1. Descriptive analyses 
Overall, 1781 long-term CRC survivors were included in the analysis. Participants were on 
average 66.1 years old at baseline and 60% were male and 40% female (Table 8). The 
tumor was located in the colon in around 60% and confined to the intestine (UICC stage I 
or II) in almost 60% of all cases. Primary treatment included radiotherapy and chemotherapy 
in 20% and 42% of cases, respectively. Five years after diagnosis, 22% of all survivors still 
had a stoma and around 9% of the survivors had experienced a CRC recurrence. Average 
pre-diagnosis PA levels were two to three times as high as post-diagnosis PA levels. 
Baseline characteristics such as living in a village, being less educated, and having <2 
comorbidities were associated with higher mean MET-h/wk pre- and post-diagnosis. The 
comparison of pre- and post-diagnosis PA quartiles revealed a weak correlation (Kendall 
rank correlation coefficient = 0.15; p <0.0001). 
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Table 8 Patient characteristics according to pre- and post-diagnosis physical activity 
  Total sample  Pre-diagnosis PAa,d 
(MET-h/wk) 
 Post-diagnosis PAb,d 
(MET-h/wk) 
  N (Col. %)  Mean (SD) p-valuef  Mean (SD) p-valuef 
Overall  1781  143.5 (107.1)   54.9 (60.4)  
Age     -   - 
30-59 years  431 (24.2)  185.1 (122.7)   57.5 (60.3)  
60-69 years  655 (36.8)  157.4 (112.4)   58.8 (59.0)  
70-79 years  560 (31.4)  109.7 (76.2)   53.6 (63.7)  
80+ years  135 (7.6)  82.8 (55.0)   33.4 (47.1)  
Mean (SD)  66.1 (9.9)       
Sex     0.5432   0.1260 
Female  706 (39.6)  145.4 (95.0)   52.2 (58.6)  
Male  1075 (60.4)  142.2 (114.3)   56.7 (61.4)  
Marital statusc     0.0008   0.0480 
Unmarried  89 (5.0)  152.0 (113.8)   56.6 (54.3)  
Married  1338 (75.1)  146.8 (110.6)   56.2 (60.3)  
Divorced  106 (6.0)  147.9 (111.5)   54.5 (66.5)  
Widowed  245 (13.8)  120.5 (77.4)   47.4 (59.9)  
Residential area     0.0022   0.0005 
Village (<10,000)  635 (35.7)  152.9 (125.2)   62.1 (67.5)  
Small town  611 (34.3)  142.5 (102.1)   51.6 (55.5)  
City (>100,000)  535 (30.0)  133.6 (86.8)   50.0 (55.7)  
Educationc     <0.0001   0.0613 
≤9 years   1153 (64.7)  151.1 (115.9)   56.8 (64.2)  
10-11 years  312 (17.5)  131.9 (88.8)   52.9 (55.8)  
≥12 years  313 (17.6)  127.0 (84.9)   50.0 (49.0)  
BMI (kg/m2)c     0.9075   0.2659 
<25  651 (36.6)  146.5 (105.1)   55.4 (60.3)  
25-30  781 (43.9)  139.2 (101.8)   56.7 (60.0)  
>30  347 (19.5)  147.9 (121.5)   49.9 (61.2)  
Smokingc     0.0391   0.9625 
Never  763 (43.0)  141.2 (101.2)   54.2 (59.9)  
Former (>1 year)  760 (42.8)  140.0 (107.6)   56.5 (60.0)  
Current  253 (14.3)  162.4 (121.4)   52.5 (63.2)  
Alcohol (grams/day)d     0.6470   0.0023 
None  456 (25.6)  141.1 (105.1)   47.0 (57.7)  
0.9-6.1  360 (20.2)  148.5 (115.5)   52.9 (58.6)  
>6.1-14.4  292 (16.4)  148.1 (106.2)   57.3 (56.7)  
>14.4-30.7  330 (18.5)  141.6 (103.3)   64.6 (63.2)  
>30.7  319 (17.9)  139.2 (102.6)   55.3 (65.2)  
Comorbiditiesc,g     <0.0001   0.0004 
<2  945 (53.1)  160.8 (113.0)   59.7 (62.7)  
≥2  835 (46.9)  124.2 (96.5)   49.4 (57.1)  
Cancer sitec     0.0779   0.9296 
Proximal colon  524 (29.4)  136.2 (109.4)   54.6 (61.0)  
Distal colon  510 (28.6)  145.4 (108.9)   55.7 (59.8)  
Rectum  742 (41.7)  147.4 (104.1)   54.4 (60.2)  
Cancer stagec     0.2813   0.2810 
I  511 (28.7)  145.6 (103.4)   59.1 (60.3)  
II  616 (34.6)  134.0 (107.4)   51.7 (61.0)  
III  591 (33.2)  151.6 (109.7)   54.5 (59.2)  
IV  56 (3.1)  147.9 (109.2)   55.4 (66.9)  
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Table 8 Patient characteristics according to pre- and post-diagnosis physical activity 
(continued) 
  Total sample  Pre-diagnosis PAa,d 
(MET-h/wk) 
 Post-diagnosis PAb,d 
(MET-h/wk) 
  N (Col. %)  Mean (SD) p-valuef  Mean (SD) p-valuef 
Overall  1781  143.5 (107.1)   54.9 (60.4)  
Radiotherapyc     0.0960   0.8332 
Yes  353 (19.8)  152.1 (108.1)   55.5 (62.8)  
No  1427 (80.1)  141.5 (106.8)   54.7 (59.8)  
Chemotherapyc     <0.0001   0.5153 
Yes  751 (42.2)  156.0 (113.3)   53.8 (59.2)  
No  1029 (57.8)  134.5 (101.4)   55.7 (61.3)  
Stomae until 5YFU     0.5526   0.1891 
Yes  405 (22.7)  141.3 (99.0)   51.8 (60.4)  
No  1327 (74.5)  144.9 (109.8)   56.3 (60.5)  
Recurrencec until 5YFU     0.1294   0.0659 
Yes  162 (9.1)  155.5 (115.2)   45.6 (57.2)  
No  1617 (90.8)  142.5 (106.2)   55.9 (60.6)  
alast age decade before diagnosis; bat five-year follow-up; c1-10 missings; d11-27; e47 missings; flinear model age-adjusted; 
gincluding heart attack, heart failure, stroke, diabetes, depression, other cancers, hypotension, circulatory disturbances heart, 
circulatory disturbances brain, circulatory disturbances legs, gout, arthritis, rheumatism, arthros is, morbus crohn, colitis 
ulcerosa; PA: physical activity; MET-h/wk: metabolic equivalent hours per week; Col.: column; SD: standard deviation; BMI: 
body mass index; 5YFU: five-year follow-up; apart from post-diagnosis PA, stoma, and recurrence all presented variables 
only include baseline information 
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3.2.1.2. Association of pre- and post-diagnosis physical activity with quality 
of life 
Survivors reporting higher pre-diagnosis PA did not have significant or clinically relevant 
higher scores on any of the QOL functioning scales or global QOL, compared to survivors 
reporting lower pre-diagnosis PA, apart from physical functioning which was significantly 
associated with Q2 and Q3 versus Q1 (Figure 2). In contrast, higher post-diagnosis PA 
quartiles were positively and significantly associated with all QOL functioning scales and 
global QOL (Figure 3). The observed differences in physical, role, and social functioning 
and global QOL were of clinical relevance. 
 
Figure 2 Associations of pre-diagnosis physical activity with global health/QOL (global QOL) 
and QOL functioning scales. Q: physical activity quartile; QOL: quality of life; BMI: body mass 
index; linear regression analyses adjusted for age at baseline, sex, marital status, residential 
area, education, number of comorbidities at baseline, alcohol intake at baseline, smoking at 
baseline, BMI at baseline, cancer site, cancer stage, treatment, stoma 
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Figure 3 Associations of post-diagnosis physical activity with global health/QOL (global QOL) 
and QOL functioning scales. Q: physical activity quartile; QOL: quality of life; 5YFU: five-year 
follow-up; BMI: body mass index; linear regression analyses adjusted for age at 5YFU, sex, 
marital status, residential area, education, number of comorbidities including information 
from baseline until 5YFU, alcohol intake at 5YFU, smoking including information from 
baseline until 5YFU, BMI at 5YFU, cancer site, cancer stage, treatment, stoma 
Of the symptom scales only nausea and vomiting was significantly associated with pre-
diagnosis PA (Q2 vs. Q1) (Figure 4). Contrarily, the cross-sectional analysis revealed 
statistically significant and inverse associations between post-diagnosis PA and almost all 
symptom scales with clinically relevant differences for fatigue, pain, and dyspnoea (Figure 
5). In addition, a significant trend was observed for post-diagnosis PA and all scales of the 
QLQ-C30, except for insomnia and diarrhoea. In sensitivity analyses using lifetime PA 
instead of PA of the last decade, to investigate the association between pre-diagnosis PA 
and QOL, the aforementioned pattern of the results did not change (data not shown). 
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3.2.1.3. Associations between changes in physical activity from pre- to post-
diagnosis and quality of life 
Active maintainers and increasers showed significantly higher scores on all QOL functioning 
scales and global QOL compared to inactive maintainers (Figure 6). Moreover, active 
maintainers and increasers scored significantly lower on almost all QOL symptom scales 
compared to inactive maintainers (Figure 7). Clinically relevant differences were observed 
for physical, role, and social functioning, global QOL, fatigue, and pain. No differences in 
QOL were found when comparing decreasers to inactive maintainers. 
 
Figure 6 Associations of changes in physical activity from pre- to post-diagnosis with global 
health/QOL (global QOL) and QOL functioning scales. AM: active maintainers, I: increasers, 
D: decreasers, IM: inactive maintainers; QOL: quality of life; 5YFU: five-year follow-up; BMI: 
body mass index; linear regression analyses adjusted for age at 5YFU, sex, marital status, 
residential area, education, number of comorbidities including information from baseline until 
5YFU, alcohol intake at 5YFU, smoking including information from baseline until 5YFU, BMI 
at 5YFU, cancer site, cancer stage, treatment, stoma 
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3.2.1.4. Different domains/ intensities of pre-diagnosis physical activity and 
quality of life 
Pre-diagnosis leisure time PA (per 100 MET-h/wk) was positively and significantly 
associated with global QOL and physical and cognitive functioning and negatively 
associated with dyspnoea. In contrast, increased pre-diagnosis work-related PA (per 100 
MET-h/wk) was significantly associated with decreased physical, role, emotional, and 
cognitive functioning and increased fatigue, pain, insomnia, appetite loss, and financial 
difficulties (Figure 8). Although pre-diagnosis moderate PA showed to have the largest 
effects, no significant associations were found for pre-diagnosis light or moderate PA with 
QOL. However, increased pre-diagnosis vigorous PA (per 100 MET-h/wk) was significantly 
associated with decreased emotional and cognitive functioning and increased fatigue, 
insomnia, and financial difficulties (Figure 9). None of the reported associations between 
pre-diagnosis PA (domains/intensities) and QOL were of clinical relevance. 
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Figure 8 Associations between different domains of pre-diagnosis physical activity and 
quality of life. PA: physical activity; CI: confidence interval; BMI: body mass index; linear 
regression analyses adjusted for age at baseline, sex, marital status, residential area, 
education, number of comorbidities at baseline, alcohol intake at baseline, smoking at 
baseline, BMI at baseline, cancer site, cancer stage, treatment, stoma, leisure time PA or work-
related; leisure time including walking, cycling, sports; work-related PA including light work, 
hard work 
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Figure 9 Associations between different intensities of pre-diagnosis physical activity and 
quality of life. PA: physical activity; CI: confidence interval; BMI: body mass index; linear 
regression analyses adjusted for age at baseline, sex, marital status, residential area, 
education, number of comorbidities at baseline, alcohol intake at baseline, smoking at 
baseline, BMI at baseline, cancer site, cancer stage, treatment, stoma, light or moderate or 
vigorous PA; light PA including light work; moderate PA including walking; vigorous 
including hard work, cycling, sports 
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3.2.2. Association between physical activity and fatigue 
3.2.2.1. Descriptive analyses 
The characteristics of the 1781 CRC patients according to pre- and post-diagnosis PA have 
been already described in section 3.2.1.1. 
3.2.2.2. Association of pre- and post-diagnosis physical activity with fatigue 
As shown in Figure 10, survivors who were physically active pre-diagnosis did not report 
significantly lower physical, cognitive, or affective fatigue five years post-diagnosis 
compared to survivors who were physically inactive pre-diagnosis. Pre-diagnosis PA also 
explained very little of the variance of long-term fatigue with 0.2% on the physical, 0.06% 
on the cognitive fatigue, and 0.1% on the affective fatigue scale.  
In contrast, higher post-diagnosis PA was significantly associated with lower physical, 
cognitive, and affective fatigue with the strongest association for physical fatigue. Only the 
association between Q2 vs. Q1 was not significantly associated with lower cognitive fatigue 
(Figure 11). Post-diagnosis PA explained around 30% of the variability of physical fatigue 
but only approximately 1% of the variability of cognitive and affective fatigue. Additionally, 
a significant trend was observed for post-diagnosis PA and all fatigue scales.  
In sensitivity analyses using lifetime PA instead of PA of the last decade, to investigate the 
association between pre-diagnosis PA and fatigue, the aforementioned pattern of the 
results did not change (data not shown).  
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3.2.2.3. Associations between changes in physical activity from pre- to post-
diagnosis and fatigue 
Active maintainers and increasers scored significantly lower on all fatigue scales compared 
to inactive maintainers with the strongest associations for physical fatigue (Figure 12). No 
differences were found when comparing decreasers to inactive maintainers. 
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3.2.2.4. Different domains/ intensities of pre-diagnosis physical activity and 
fatigue 
No association was found between increased pre-diagnosis leisure time PA (per 100 MET-
h/wk) and any of the fatigue scales. Increased pre-diagnosis work-related PA (per 100 MET-
h/wk) was significantly associated with increased levels of physical, cognitive, and affective 
fatigue (Figure 13). No associations were found for pre-diagnosis light or moderate PA with 
fatigue, apart from increased pre-diagnosis moderate PA (per 100 MET-h/wk) being 
significantly associated with lower affective fatigue. In contrast, increased pre-diagnosis 
vigorous PA (per 100 MET-h/wk) was significantly associated with increased physical, 
cognitive, and affective fatigue (Figure 14). 
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3.2.3. Potential determinants of physical inactivity 
3.2.3.1. Descriptive analyses 
Descriptive analyses of PA at 5YFU overall and according to patient characteristics, before 
and after imputation, are summarized in Table 9. The mean age of the 1343 patients at 
baseline was 66.2 years. More than half of the patients were male (60.5%), and almost all 
were German. At baseline, average PA levels were more than twice as high as PA levels 
reported at 5YFU. The tumor was located in the colon in around 60% of patients and 
confined to the intestine (UICC stage I or II) in two thirds of all cases. Primary treatment 
included radiation and chemotherapy in 20% and 42% of cases, respectively, and surgery 
resulted in a stoma in 28% of all patients. Five years later, the proportion of patients still 
having a stoma was 21%. During the 5YFU period, the tumor recurred in 9% of all surviving 
patients. The proportion of patients reporting to drink alcohol or to smoke cigarettes 
declined. In contrast, the proportion of obese patients increased from 20% to 25%. 
Baseline characteristics such as older age, living in communities with 10,000 or more 
inhabitants, having ≥2 comorbidities, and being obese, as well as information from the 
5YFU, such as still having a stoma, were associated with lower mean PA levels at 5YFU in 
the descriptive analyses. In particular, PA at baseline was shown to be strongly correlated 
with PA at 5YFU. Means (SD) calculated on imputed data did not substantially differ from 
means (SD) calculated on unimputed data. 
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Table 9 Description of study population and crude association of patient characteristics with 
physical activity at five-year follow-up before and after multiple imputation of missing data 
 Before Multiple Imputation  After Multiple Imputation 
 
Patients  
PAd at 5YFU 
(MET-h/wk) 
 Patients  
PA at 5YFU 
(MET-h/wk) 
Total N (Col%)  Mean (SD) p-valuee  N (Col%)  Mean (SD) 
 1343   60.3 (60.6)   1343   59.9 (60.4) 
Baseline characteristics 
Age             
Mean (SD) = 66.2 (9.7) years           
 30-59 years 316 (23.5)  61.2 (63.0) 0.0227  316 (23.5)  61.0 (62.8) 
 60-69 years 511 (38.1)  61.2 (57.5)  511 (38.1)  61.1 (57.6) 
 70-79 years 417 (31.1)  61.6 (64.6)  417 (31.1)  61.5 (64.3) 
 80+ years 99 (7.4)  43.9 (46.6)  99 (7.4)  44.2 (45.8) 
Sex             
 female 530 (39.5)  56.6 (59.4) 0.0599  530 (39.5)  56.0 (58.9) 
 male 813 (60.5)  62.7 (61.3)  813 (60.5)  62.5 (61.2) 
Marital statusa             
 single 70 (5.2)  59.8 (57.0) 0.0911  70 (5.2)  59.5 (57.0) 
 married 1007 (75.0)  62.0 (61.0)  1009 (75.1)  61.7 (60.9) 
 divorced 76 (5.7)  61.2 (70.7)  76 (5.7)  61.1 (69.9) 
 widowed 187 (13.9)  51.2 (54.8)  188 (14.0)  50.3  (53.7) 
Residential area             
 village (<10,000) 471 (35.1)  69.8 (67.6) 0.0022  471 (35.1)  69.2 (67.1) 
 small town 461 (34.3)  55.8 (55.1)  461 (34.3)  55.8 (55.2) 
 city (>100,000) 411 (30.6)  54.3 (56.7)  411 (30.6)  54.1 (56.6) 
Citizenshipa             
 German 1301 (96.9)  60.4 (60.5) 0.5280  1305 (97.2)  60.1 (60.3) 
 other 38 (2.8)  56.9 (66.4)  38 (2.8)  56.2 (64.6) 
Educationa             
 ≤9 years 898 (66.9)  62.8 (63.4) 0.4540  899 (66.9)  62.2 (62.9) 
 10-11 years 222 (16.5)  59.6 (59.4)  222 (16.5)  59.1 (58.8) 
 >12 years 221 (16.5)  51.9 (49.8)  222 (16.5)  51.7 (49.8) 
Cancer sitea             
 proximal colon 403 (30.0)  59.8 (62.5) 0.6383  406 (30.2)  59.6 (61.9) 
 distal colon 387 (28.8)  61.0 (59.2)  387 (28.8)  60.6 (59.1) 
 rectum 550 (41.0)  60.1 (60.5)  550 (41.0)  59.7 (60.2) 
Cancer stagea             
 I 392 (29.2)  63.3 (60.8) 0.1055  394 (29.3)  62.7 (60.3) 
 II 468 (34.9)  57.2 (62.4)  471 (35.1)  57.0 (61.8) 
 III 439 (32.7)  60.7 (58.3)  440 (32.8)  60.8 (58.7) 
 IV 38 (2.8)  59.8 (65.4)  38 (2.8)  58.2 (63.9) 
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Table 9 Description of study population and crude association of patient characteristics with 
physical activity at five-year follow-up before and after multiple imputation of missing data 
(continued) 
 Before Multiple Imputation  After Multiple Imputation 
 Patients  
PAd at 5YFU 
(MET-h/wk) 
 Patients  
PA at 5YFU 
(MET-h/wk) 
Total N (Col%)  Mean (SD) p-valuee  N (Col%)  Mean (SD) 
 1343   60.3 (60.6)   1343   59.9 (60.4) 
Baseline characteristics 
Radiationa             
 yes 267 (19.9)  58.0 (60.1) 0.3113  268 (20.0)  57.8 (60.0) 
 no 1074 (80.0)  60.9 (60.8)  1075 (80.0)  60.5 (60.5) 
Chemotherapya             
 yes 559 (41.6)  58.9 (58.5) 0.5917  560 (41.7)  58.9 (58.5) 
 no 783 (58.3)  61.3 (62.1)  783 (58.3)  60.7 (61.7) 
Stoma             
 yes 376 (28.0)  58.8 (61.6) 0.1843  377 (28.1)  58.5 (61.2) 
 no 963 (71.7)  60.9 (60.3)  966 (71.9)  60.5 (60.1) 
Comorbiditiesa,f             
 <2 697 (51.9)  63.1 (62.7) 0.0158  697 (51.9)  62.8 (62.5) 
 ≥2 645 (48.0)  57.1 (57.9)  646 (48.1)  56.8 (57.9) 
Physical activity (MET-h/wk)b           
 Mean (SD) = 144.4 (111.7)           
 Q1 (<70) 330 (24.6)  46.9 (52.5) <.0001  336 (25.0)  48.1 (53.0) 
 Q2 (70-117) 331 (24.7)  58.4 (59.8)  335 (24.9)  58.2 (59.5) 
 Q3 (117-184) 331 (24.7)  59.0 (53.8)  333 (24.8)  59.2 (54.2) 
 Q4 (>184) 331 (24.7)  74.3 (71.0)  339 (25.2)  74.2 (70.5) 
Alcohol (grams/day)b            
 none 339 (25.2)  52.8 (55.6) 0.0188  346 (25.8)  52.3 (55.0) 
 0.1-5.5 209 (15.6)  57.5 (62.2)  211 (15.7)  58.3 (62.0) 
 >5.5-13.5 260 (19.4)  64.1 (59.1)  265 (19.7)  64.4 (59.7) 
 >13.5-29.5 250 (18.6)  64.4 (63.7)  254 (18.9)  64.1 (63.2) 
 >29.5 266 (19.8)  63.4 (63.3)  267 (19.9)  62.8 (63.0) 
Smokinga             
 never 584 (43.5)  60.8 (62.2) 0.0724  585 (43.6)  60.3 (61.7) 
 former  568 (42.3)  61.5 (58.3)  568 (42.3)  61.2 (58.5) 
 current 189 (14.1)  55.1 (62.6)  190 (14.2)  55.1 (61.7) 
BMI (kg/m2)a             
 <25 484 (36.0)  59.8 (60.0) 0.0154  485  (36.1)  59.6 (60.0) 
 25-30 590 (43.9)  63.5 (61.8)  591  (44.0)  63.5 (61.7) 
 >30 267 (19.9)  53.4 (58.7)  267  (19.9)  52.8 (57.8) 
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Table 9 Description of study population and crude association of patient characteristics with 
physical activity at five-year follow-up before and after multiple imputation of missing data 
(continued) 
 Before Multiple Imputation  After Multiple Imputation 
 Patients  
PAd at 5YFU 
(MET-h/wk) 
 Patients  
PA at 5YFU 
(MET-h/wk) 
Total N (Col%)  Mean (SD) p-valuee  N (Col%)  Mean (SD) 
 1343   60.3 (60.6)   1343   59.9 (60.4) 
5YFU characteristics 
Stomac             
 yes 286 (21.3)  55.7 (59.1) 0.0416  295  (22.0)  55.7 (58.9) 
 no 1010 (75.2)  61.9 (61.2)  1048  (78.0)  61.1 (60.8) 
Comorbiditiesa,f             
 <2 668 (49.7)  63.8 (63.2) 0.0052  669  (49.8)  63.7 (63.1) 
 ≥2 674 (50.2)  56.6 (57.4)  674  (50.2)  56.3 (57.4) 
Recurrencea             
 yes 120 (8.9)  51.9 (57.7) 0.0605  120  (8.9)  52.1 (57.9) 
 no 1222 (91.0)  61.1 (60.8)  1223  (91.1)  60.7 (60.6) 
Alcohol (grams/day)b            
 none 513 (38.2)  59.3 (62.3) 0.0471  522  (38.9)  58.6 (61.6) 
 0.1-5.5 145 (10.8)  52.2 (52.3)  148  (11.0)  52.0 (52.2) 
 >5.5-13.5 311 (23.2)  58.0 (55.8)  315  (23.5)  57.9 (55.9) 
 >13.5-29.5 231 (17.2)  69.0 (64.6)  232  (17.3)  69.0 (64.8) 
 >29.5 123 (9.2)  63.7 (65.8)  126  (9.4)  63.2 (65.2) 
Smokingb             
 never 575 (42.8)  60.7 (61.8) 0.3387  581  (43.3)  59.9 (61.3) 
 former  646 (48.1)  59.9 (57.3)  651  (48.5)  59.7 (57.4) 
 current 109 (8.1)  60.3 (73.8)  111  (8.3)  61.2 (72.3) 
BMI (kg/m2)a             
 <25 424 (31.6)  61.6 (60.1) 0.0272  425  (31.7)  61.8 (60.3) 
 25-30 576 (42.9)  62.1 (61.7)  581  (43.3)  61.8 (61.5) 
 >30 334 (24.9)  54.9 (59.0)  337  (25.1)  54.5 (58.4) 
a1-10 missings; b11-20 missings; c47 missings; d130 missings; eKruskal-Wallis-Test; fincluding heart attack, heart failure, 
stroke, diabetes, depression, other cancers, hypotension, circulatory disturbances heart, circulatory disturbances brain, 
circulatory disturbances legs, gout, arthritis, rheumatism, arthrosis; PA: physical activity; 5YFU: five-year follow-up; MET-
h/wk: metabolic equivalent hours per week; Col.: column; SD: standard deviation; Q: quartile; BMI: body mass index 
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3.2.3.2. Physical inactivity: bivariate and multivariate analyses 
The results of the bivariate and multivariable analyses of the association between patient 
characteristics and physical inactivity are displayed in Table 10 (baseline characteristics, 
models 1 and 2) and Table 11 (baseline and 5YFU characteristics, models 3-5). 
Both bivariate and multivariable analyses showed a fairly homogenous pattern with respect 
to potential determinants of physical inactivity. Older age, being divorced, living in a more 
populated residential area, stage II cancer, a higher number of comorbidities, having a 
stoma, current smoking, and a higher BMI were associated with physical inactivity, 
irrespective of the modeling strategy applied and with minor variations regarding the 
strength and significance of each specific association in models 1 to 5. Baseline PA itself 
represented a strong predictor of PA at 5YFU (p trend <0.0001). Inclusion of baseline PA 
in multivariable analyses slightly attenuated the association of age at baseline, cancer 
stage, and comorbidities with physical inactivity at 5YFU, but it did not substantially affect 
the model-building process, which implies that variables selected by the selection algorithm 
did not substantially change between different models (models 2, 4, and 5). With respect to 
time-varying factors, such as alcohol consumption, smoking, BMI, and comorbidities, the 
replacement of baseline information by pertinent information from the 5YFU substantially 
affected neither the model estimates nor the model-building process (models 1-4). Likewise, 
the inclusion of disease recurrence as a potential covariate did not alter the effect estimates 
of the other potential determinants (model 5). Only alcohol consumption at 5YFU seemed 
to be more strongly associated with physical inactivity compared to alcohol consumption at 
baseline. 
Considering only baseline variables as potential determinants of physical inactivity (Table 
10), the model with the best model fit was model 2. According to this model, having a stoma 
(OR = 1.51, 95% CI = 1.12-2.04), living in a small town or city (OR = 1.46, 95% CI = 1.05-
2.02; OR = 1.42, 95% CI = 1.01-2.02), and being a current smoker (OR = 1.54, 95% 
CI = 1.04-2.29) was significantly associated with an increased likelihood of being physically 
inactive five years after diagnosis. Further, survivors physically active at baseline were 
significantly less likely to be physically inactive at 5YFU. In addition, survivors being older, 
divorced, obese, having ≥2 comorbidities, or with stage II disease were more likely to be 
physically inactive. However, the latter results were not of statistical significance, and no 
clear monotonic trend between stage and physical inactivity was observed. 
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Table 10 Potential baseline determinants of physical inactivity among colorectal cancer 
survivors five years post-diagnosis 
 
  Model 1 
No adjustment for 
baseline PA nor 
recurrence  
Model 2 
Adjustment for 
baseline PA, no 
adjustment for recurrence  
 PIA
% 
Bivariate analysis 
OR (CI 95%) 
Backward selection 
OR (CI 95%) 
Backward selection 
OR (CI 95%) 
Age     
30-59 years 22.4 ref ref ref 
60-69 years 21.8 0.97 (0.69; 1.38) 0.96 (0.66; 1.38) 0.90 (0.62; 1.31) 
70-79 years 30.0 1.44 (1.01; 2.06) 1.48 (1.00; 2.22) 1.20 (0.79; 1.82) 
80+ years 33.8 1.71 (1.00; 2.90) 1.89 (1.05; 3.42) 1.44 (0.80; 2.58) 
Sex     
female 26.4 ref ref ref 
male 24.4 0.89 (0.68; 1.15) 1.07 (0.77; 1.47) 1.00 (0.73; 1.37) 
Marital status     
married 23.6 ref ref ref 
single 29.2 1.31 (0.75; 2.27) 1.31 (0.74; 2.33) 1.28 (0.70; 2.34) 
divorced 35.3 1.67 (0.99; 2.80) 1.60 (0.93; 2.78) 1.72 (0.96; 3.07) 
widowed 27.8 1.26 (0.87; 1.83) 1.00 (0.65; 1.52) 1.00 (0.66; 1.53) 
Residential area     
village (<10,000) 21.1 ref ref ref 
small town 27.0 1.37 (1.00; 1.87) 1.42 (1.03; 1.95) 1.46 (1.05; 2.02) 
city (>100,000) 27.7 1.44 (1.04; 2.00) 1.37 (0.97; 1.94) 1.42 (1.01; 2.02) 
Citizenship     
German 25.1 ref - - 
other 27.3 1.12 (0.53; 2.40)   
Education     
≤9 years 26.6 1.16 (0.81; 1.64) - 1.04 (0.71; 1.53) 
10-11 years 20.7 0.86 (0.54; 1.36)  0.76 (0.47; 1.23) 
>12 years 23.8 ref  ref 
Cancer site     
rectum 26.2 ref - - 
proximal colon 27.5 1.04 (0.76; 1.41)   
distal colon 21.4 0.79 (0.57; 1.09)   
Cancer stage     
I 21.0 ref ref ref 
II 29.5 1.51 (1.09; 2.10) 1.42 (1.01; 2.00) 1.38 (0.98; 1.94) 
III 23.9 1.15 (0.81; 1.63) 1.12 (0.78; 1.60) 1.13 (0.79; 1.63) 
IV 32.4 1.76 (0.83; 3.74) 1.88 (0.86; 4.12) 1.79 (0.81; 3.95) 
Radiation     
yes 28.6 1.23 (0.90; 1.69) - - 
no 24.3 ref   
Chemotherapy     
yes 25.9 1.06 (0.81; 1.38) - - 
no 24.6 ref   
Comorbidities     
<2 21.7 ref ref ref 
≥2 29.1 1.45 (1.11; 1.88) 1.32 (0.99; 1.76) 1.24 (0.92; 1.66) 
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Table 10 Potential baseline determinants of physical inactivity among colorectal cancer 
survivors five years post-diagnosis (continued) 
 
  Model 1 
No adjustment for 
baseline PA nor 
recurrence  
Model 2 
Adjustment for 
baseline PA, no 
adjustment for recurrence  
 PIA
% 
Bivariate analysis 
OR (CI 95%) 
Backward selection 
OR (CI 95%) 
Backward selection 
OR (CI 95%) 
Stoma     
yes 30.1 1.40 (1.06; 1.85) 1.57 (1.17; 2.11) 1.51 (1.12; 2.04) 
no 23.2 ref ref ref 
Physical activity (MET-h/wk)     
Q1 (<75.2) 34.8 ref - ref 
Q2 (≥75.2-121.2) 27.2 0.74 (0.53; 1.05)  0.74 (0.51; 1.06) 
Q3 (≥121.2-185.0) 23.2 0.59 (0.42; 0.84)  0.64 (0.44; 0.92) 
Q4 (≥185.0) 16.8 0.40 (0.27; 0.58)  0.45 (0.30; 0.68) 
 
Alcohol (grams/day)     
none 28.7 ref ref ref 
0.1-5.5 31.4 1.05 (0.71; 1.57) 1.14 (0.75; 1.73) 1.17 (0.77; 1.77) 
>5.5-13.5 22.4 0.69 (0.47; 1.03) 0.75 (0.49; 1.13) 0.77 (0.50; 1.17) 
>13.5-29.5 21.0 0.64 (0.43; 0.96) 0.68 (0.44; 1.05) 0.71 (0.46; 1.10) 
>29.5 23.3 0.75 (0.51; 1.11) 0.77 (0.50; 1.17) 0.78 (0.51; 1.21) 
Smoking     
never 25.8 ref ref ref 
former (>1 year) 21.6 0.82 (0.61; 1.09) 0.80 (0.59; 1.10) 0.80 (0.58; 1.09) 
current 33.7 1.39 (0.96; 2.00) 1.48 (1.00; 2.20) 1.54 (1.04; 2.29) 
BMI (kg/m2)     
<25 23.9 ref ref ref 
25-30 23.8 0.99 (0.73; 1.33) 1.03 (0.75; 1.41) 1.02 (0.74; 1.40) 
>30 30.8 1.42 (0.99; 2.03) 1.46 (0.99; 2.16) 1.43 (0.96; 2.13) 
Mean (SD) AIC over 
imputed data sets 
  1497.90 (10.95) 1487.06 (10.85) 
PA: physical activity; PIA %: percentages of inactive participants, calculated on unimputed data; OR: odds ratio; CI: 
confidence interval; ref: reference group; MET-h/wk: metabolic equivalent hours per week; Q: quartile; BMI: body mass index; 
SD: standard deviation; AIC: Akaike information criterion; PA quartiles based on MET-h/wk for PA at baseline and five-year 
follow-up: Q1=physically inactive, Q2-Q4= physically active; OR >1 are in favor of physical inactivity yes 
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Table 11 Potential baseline and five-year follow-up determinants of physical inactivity among 
colorectal cancer survivors five years post-diagnosis 
 
  Model 3 
No adjustment for 
baseline PA nor 
recurrence 
Model 4 
Adjustment for 
baseline PA, 
no adjustment for 
recurrence 
Model 5 
Adjustment for 
baseline PA and 
recurrence 
 PIA 
% 
Bivariate 
analysis 
OR (CI 95%) 
Backward 
Selection 
OR (CI 95%) 
Backward 
Selection 
OR (CI 95%) 
Backward 
Selection 
OR (CI 95%) 
Determinants at baseline 
Age      
30-59 years 22.4 ref ref ref ref 
60-69 years 21.8 0.97 (0.69; 1.38) 0.94 (0.65; 1.35) 0.91 (0.63; 1.31) 0.92 (0.64; 1.33) 
70-79 years 30.0 1.44 (1.01; 2.06) 1.43 (0.96; 2.12) 1.20 (0.80; 1.80) 1.21 (0.81; 1.82) 
80+ years 33.8 1.71 (1.00; 2.90) 1.75 (0.96; 3.19) 1.37 (0.74; 2.55) 1.40 (0.76; 2.61) 
Sex      
female 26.4 ref ref ref ref 
male 24.4 0.89 (0.68; 1.15) 1.01 (0.74; 1.39) 1.02 (0.74; 1.40) 1.00 (0.73; 1.39) 
Marital status      
married 23.6 ref ref ref ref 
single 29.2 1.31 (0.75; 2.27) 1.37 (0.77; 2.44) 1.33 (0.75; 2.37) 1.32 (0.74; 2.36) 
divorced 35.3 1.67 (0.99; 2.80) 1.70 (0.98; 2.95) 1.68 (0.96; 2.93) 1.69 (0.97; 2.95) 
widowed 27.8 1.26 (0.87; 1.83) 1.07 (0.70; 1.64) 1.09 (0.71; 1.66) 1.08 (0.71; 1.66) 
Residential area      
village (<10,000) 21.1 ref ref ref ref 
small town 27.0 1.37 (1.00; 1.87) 1.40 (1.01; 1.93) 1.43 (1.04; 1.99) 1.43 (1.03; 1.98) 
city (>100,000) 27.7 1.44 (1.04; 2.00) 1.38 (0.98; 1.95) 1.38 (0.98; 1.96) 1.38 (0.97; 1.96) 
Citizenship      
German 25.1 ref - - - 
other 27.3 1.12 (0.53; 2.40)    
Education      
≤9 years 26.6 1.16 (0.81; 1.64) - - - 
10-11 years 20.7 0.86 (0.54; 1.36)    
>12 years 23.8 ref    
Cancer site      
rectum 26.2 ref ref - - 
proximal colon 27.5 1.04 (0.76; 1.41) 1.00 (0.69; 1.46)   
distal colon 21.4 0.79 (0.57; 1.09) 0.79 (0.55; 1.15)   
Cancer stage      
I 21.0 ref ref ref ref 
II 29.5 1.51 (1.09; 2.10) 1.38 (0.98; 1.96) 1.35 (0.96; 1.91) 1.35 (0.96; 1.91) 
III 23.9 1.15 (0.81; 1.63) 1.04 (0.72; 1.49) 1.06 (0.73; 1.53) 1.05 (0.73; 1.51) 
IV 32.4 1.76 (0.83; 3.74) 1.70 (0.77; 3.74) 1.65 (0.74; 3.67) 1.53 (0.68; 3.45) 
Radiation      
yes 28.6 1.23 (0.90; 1.69) - - - 
no 24.3 ref    
Chemotherapy      
yes 25.9 1.06 (0.81; 1.38) - - - 
no 24.6 ref    
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Table 11 Potential baseline and five-year follow-up determinants of physical inactivity 
among colorectal cancer survivors five years post-diagnosis (continued) 
 
  Model 3 
No adjustment for 
baseline PA nor 
recurrence 
Model 4 
Adjustment for 
baseline PA, 
no adjustment for 
recurrence 
Model 5 
Adjustment for 
baseline PA and 
recurrence 
 PIA 
% 
Bivariate 
analysis 
OR (CI 95%) 
Backward 
Selection 
OR (CI 95%) 
Backward 
Selection 
OR (CI 95%) 
Backward 
Selection 
OR (CI 95%) 
Determinants at baseline 
Physical activity  
(MET-h/wk) 
     
Q1 (<75.2) 34.8 ref - ref ref 
Q2 (≥75.2-121.2) 27.2 0.74 (0.53; 1.05)  0.74 (0.52; 1.07) 0.74 (0.52; 1.06) 
Q3 (≥121.2-185.0) 23.2 0.59 (0.42; 0.84)  0.64 (0.45; 0.93) 0.64 (0.44; 0.93) 
Q4 (≥185.0) 16.8 0.40 (0.27; 0.58)  0.45 (0.30; 0.67) 0.45 (0.30; 0.67) 
Determinants at 5YFU 
Alcohol (grams/day)      
none 27.5 ref ref ref ref 
0.1-5.5 34.3 1.35 (0.89; 2.05) 1.58 (1.02; 2.45) 1.59 (1.02; 2.48) 1.59 (1.02; 2.48) 
>5.5-13.5 24.0 0.82 (0.58; 1.17) 0.91 (0.63; 1.32) 0.92 (0.64; 1.34) 0.93 (0.64; 1.35) 
>13.5-29.5 18.4 0.58 (0.39; 0.87) 0.63 (0.41; 0.97) 0.61 (0.39; 0.93) 0.61 (0.40; 0.95) 
>29.5 18.7 0.62 (0.37; 1.04) 0.66 (0.38; 1.13) 0.62 (0.36; 1.07) 0.63 (0.36; 1.09) 
Smoking      
never 25.4 ref ref ref ref 
former (>1 year) 23.3 0.88 (0.67; 1.16) 0.90 (0.67; 1.22) 0.89 (0.66; 1.21) 0.90 (0.67; 1.22) 
current 34.0 1.37 (0.88; 2.15) 1.51 (0.93; 2.45) 1.46 (0.90; 2.38) 1.47 (0.90; 2.40) 
BMI (kg/m2)      
<25 22.7 ref ref ref ref 
25-30 24.2 1.10 (0.81; 1.49) 1.19 (0.85; 1.66) 1.18 (0.84; 1.65) 1.18 (0.84; 1.65) 
>30 30.4 1.48 (1.05; 2.08) 1.58 (1.10; 2.28) 1.57 (1.09; 2.28) 1.58 (1.09; 2.28) 
Comorbidities      
<2 21.1 ref ref ref ref 
≥2 29.4 1.52 (1.17; 1.98) 1.35 (1.01; 1.81) 1.26 (0.94; 1.68) 1.26 (0.94; 1.69) 
Recurrence      
yes 31.5 1.39 (0.91; 2.11) - - 1.27 (0.80; 2.00) 
no 24.5 ref   ref 
Stoma      
yes 31.3 1.43 (1.07; 1.92) 1.52 (1.06; 2.18) 1.57 (1.14; 2.15) 1.54 (1.12; 2.12) 
no 23.1 ref ref ref ref 
Mean (SD) AIC over 
imputed data sets 
  1494.85 (10.47) 1482.48 (10.91) 1483.32 (11.00) 
 
PA: physical activity; PIA %: percentages of inactive participants, calculated on unimputed data; OR: odds ratio; CI: 
confidence interval; ref: reference group; MET-h/wk: metabolic equivalent hours per week; Q: quartile; 5YFU: five-year follow-
up; BMI: body mass index; SD: standard deviation; AIC: Akaike information criterion; PA quartiles based on MET-h/wk for 
PA at baseline and 5YFU: Q1=physically inactive, Q2-Q4= physically active; OR >1 are in favor of physical inactivity yes 
 
78 3 Results 
 
  
3.2.3.3. Subgroup analyses according to age and sex 
Overall, the aforementioned pattern did not substantially change when logistic regression 
analyses with the variables selected for model 2 (Table 10) were performed in subgroups 
according to age and sex. When testing for interaction, only the results of two subgroups 
were statistically significantly different (Table 12). 
The association between having a stoma and higher odds of being physically inactive was 
restricted to younger survivors (30-69 years). The aforementioned association between 
stage II CRC and higher odds of physical inactivity was only found in older survivors (≥70 
years). Furthermore, the association between residential area and physical inactivity was 
confined to older survivors and stronger in women than in men. Men with ≥2 comorbidities 
were more likely to be physically inactive, compared to men with <2 comorbidities, but no 
associations were found in women. In contrast, the association between BMI and physical 
inactivity was stronger in women than in men.
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 Table 12 Potential baseline determinants of physical inactivity among colorectal cancer survivors five years post-diagnosis - subgroup analyses 
Model 2 Adjustment for baseline PA, no adjustment for recurrence Backward selection 
 by age  by sex 
Total 30-69 years  70-80+ years    Women  Men   
N = 1343 PIA% OR (95% CI)  PIA% OR (95% CI)  PHeterogeneity  PIA% OR (95% CI)  PIA% OR (95% CI)  PHeterogeneity 
Age                
30-59 years - -  - -  -  18.0 ref  25.3 ref  
0.24 
60-69 years         26.4 1.36 (0.73; 2.56)  19.0 0.70 (0.43; 1.15)  
70-79 years         30.4 1.28 (0.60; 2.72)  29.8 1.16 (0.69; 1.97)  
80+ years         38.5 1.85 (0.70; 4.85)  28.6 1.06 (0.43; 2.58)  
Sex                
female 28.1 ref  38.5 ref  
0.60 
 - -  - -  - 
male 23.8 0.80 (0.52; 1.23)  28.6 1.47 (0.82; 2.65)          
Marital status                
married 23.9 ref  30.8 ref  
0.20 
 23.0 ref  23.9 ref  
0.28 
single 33.3 1.57 (0.80; 3.08)  0.0 1.09 (0.30; 3.91)   45.0 2.07 (0.74; 5.78)  22.2 1.02 (0.47; 2.21)  
divorced 36.6 1.89 (0.99; 3.62)  50.0 1.16 (0.38; 3.59)   27.5 1.18 (0.52; 2.68)  46.4 2.12 (0.93; 4.87)  
widowed 26.5 0.55 (0.24; 1.26)  38.7 1.38 (0.81; 2.35)   31.03 1.18 (0.69; 2.02)  19.6 0.76 (0.34; 1.70)  
Residential area                
village (<10,000) 21.0 ref  26.3 ref  
0.18 
 20.9 ref  21.2 ref  
0.65 small town 26.7 1.37 (0.91; 2.07)  36.4 1.77 (1.00; 3.10)   28.7 1.75 (1.01; 3.02)  25.9 1.32 (0.86; 2.01)  
city (>100,000) 29.0 1.04 (0.65; 1.68)  36.4 2.15 (1.23; 3.37)   29.2 1.53 (0.86; 2.72)  26.6 1.27 (0.81; 1.99)  
Education                
≤9 years 27.4 1.01 (0.63; 1.61)  32.5 1.05 (0.52; 2.10)  
0.65 
 28.6 1.16 (0.58; 2.29)  25.3 1.04 (0.64; 1.68)  
0.83 10-11 years 17.1 0.64 (0.35; 1.18)  37.5 0.91 (0.38; 2.17)   19.6 0.64 (0.29; 1.42)  21.8 0.78 (0.41; 1.48)  
>12 years 23.5 ref  33.3 ref   25.8 ref  23.0 ref  
Cancer site                
rectum 26.7 ref  27.3 ref  
0.45 
 29.3 ref  24.8 ref  
0.46 proximal colon 28.5 1.17 (0.68; 2.00)  41.4 0.98 (0.48; 1.98)   29.1 0.86 (0.44; 1.69)  26.2 1.05 (0.61; 1.81)  
distal colon 20.8 0.85 (0.49; 1.45)  30.4 0.91 (0.46; 1.80)   20.7 0.68 (0.34; 1.36)  22.1 1.01 (0.59; 1.72)  
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Table 12 Potential baseline determinants of physical inactivity among colorectal cancer survivors five years post-diagnosis - subgroup analyses 
(continued) 
Model 2 Adjustment for baseline PA, no adjustment for recurrence Backward selection 
 by age  by sex 
Total 30-69 years  70-80+ years    Women  Men   
N = 1343 PIA% OR (95% CI)  PIA% OR (95% CI)  PHeterogeneity  PIA% OR (95% CI)  PIA% OR (95% CI)  PHeterogeneity 
                
Cancer stage                
I 21.6 ref  24.0 ref  
0.51 
 23.7 ref  19.3 ref  
0.74 
II 30.9 1.15 (0.72; 1.83)  34.8 1.74 (1.01; 3.01)   29.2 1.22 (0.70; 2.15)  29.6 1.56 (0.98; 2.50)  
III 22.2 1.06 (0.67; 1.67)  45.8 1.21 (0.66; 2.21)   25.5 1.12 (0.63; 2.01)  22.9 1.22 (0.75; 1.97)  
IV 34.8 1.39 (0.46; 4.18)  0.0 2.32 (0.69; 7.81)   33.3 2.19 (0.47; 10.2)  32.0 1.94 (0.73; 5.13)  
Physical activity (MET-h/wk)                
Q1 (<75.2) 35.2 ref  34.4 ref  
0.38 
 41.8 ref  32.0 ref  
0.48 
Q2 (≥75.2-121.2) 28.6 0.71 (0.41; 1.23)  28.0 0.73 (0.44; 1.22)   28.4 0.59 (0.32; 1.08)  26.4 0.81 (0.50; 1.31)  
Q3 (≥121.2-185.0) 20.6 0.78 (0.47; 1.28)  46.2 0.47 (0.25; 0.88)   26.2 0.65 (0.34; 1.23)  20.7 0.62 (0.38; 1.02)  
Q4 (≥185.0) 17.4 0.44 (0.26; 0.73)  25.0 0.53 (0.25; 1.15)   13.5 0.31 (0.14; 0.70)  18.9 0.54 (0.32; 0.91)  
Alcohol (grams/day)                
none 30.5 ref  41.7 ref  
0.46 
 31.0 ref  24.5 ref   
0.1-5.5 31.3 1.18 (0.68; 2.06)  37.5 1.14 (0.59; 2.22)   21.5 0.65 (0.36; 1.18)  43.7 2.28 (1.18; 4.41)  
0.04 
>5.5-13.5 23.7 0.94 (0.55; 1.62)  28.6 0.60 (0.29; 1.23)   27.5 1.12 (0.61; 2.03)  19.2 0.78 (0.40; 1.50)  
>13.5-29.5 20.1 1.03 (0.59; 1.81)  20.0 0.42 (0.20; 0.87)   20.0 0.69 (0.32; 1.48)  21.3 0.94 (0.51; 1.76)  
>29.5 22.6 0.98 (0.56; 1.74)  30.0 0.61 (0.30; 1.25)   28.6 0.89 (0.34; 2.37)  22.6 0.99 (0.56; 1.77)  
Smoking                
never 25.3 ref  44.1 ref  
0.70 
 28.3 ref  23.0 ref  
0.64 former (>1 year) 22.2 0.82 (0.54; 1.24)  25.6 0.76 (0.46; 1.26)   19.7 0.75 (0.43; 1.32)  22.2 0.85 (0.56; 1.28)  
current 37.9 1.38 (0.85; 2.25)  0.0 1.85 (0.84; 4.07)   29.3 1.25 (0.65; 2.40)  37.1 1.62 (0.94; 2.79)  
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 Table 12 Potential baseline determinants of physical inactivity among colorectal cancer survivors five years post-diagnosis - subgroup analyses 
(continued) 
Model 2 Adjustment for baseline PA, no adjustment for recurrence Backward selection 
 by age  by sex 
Total 30-69 years  70-80+ years    Women  Men   
N = 1343 PIA% OR (95% CI)  PIA% OR (95% CI)  PHeterogeneity  PIA% OR (95% CI)  PIA% OR (95% CI)  PHeterogeneity 
BMI (kg/m2)                
<25 22.9 ref  32.5 ref  
0.82 
 20.7 ref  27.0 ref  
0.03 25-30 24.6 1.03 (0.68; 1.58)  28.6 1.04 (0.63; 1.72)   31.0 1.82 (1.10; 3.00)  20.4 0.69 (0.45; 1.08)  
>30 31.6 1.46 (0.87; 2.46)  66.7 1.59 (0.84; 3.01)   31.4 1.62 (0.85; 3.08)  30.4 1.31 (0.76; 2.23)  
Comorbidities                
<2 22.2 ref  25.9 ref  
0.60 
 22.9 ref  20.8 ref  
0.43 
≥2 28.2 1.16 (0.78; 1.73)  38.3 1.26 (0.79; 1.99)   30.3 1.08 (0.66; 1.75)  28.3 1.47 (1.00; 2.17)  
Stoma                
yes 30.7 1.81 (1.12; 2.92)  25.0 1.13 (0.57; 2.25)  
0.15 
 32.7 1.53 (0.78; 2.99)  20.1 1.49 (0.91; 2.45)  0.66 
no 23.5 ref  36.2 ref   24.8 ref  21.9 ref   
PA: physical activity; PIA %: percentages of inactive participants, calculated on unimputed data; OR: odds ratio; CI: confidence interval; ref: reference group; MET-h/wk: metabolic equivalent hours per 
week; Q: quartile; BMI: body mass index; PA quartiles based on MET-h/wk for PA at baseline and five-year follow-up: Q1=physically inactive, Q2-Q4= physically active; OR >1 are in favor of physical 
inactivity yes 
 
82 4 Discussion 
 
  
4. DISCUSSION 
4.1. Systematic review of the association between physical activity and 
quality of life in long-term colorectal cancer survivors 
The results from the systematic review demonstrate that long-term CRC survivors who were 
more physically active generally reported higher QOL than non-active survivors. Moreover, 
different PA intensities such as light PA and moderate to vigorous PA seemed to be 
positively associated with QOL in long-term CRC survivors. The association between PA 
and QOL appeared to be stronger among women than among men. However, no general 
conclusion can be drawn, since only few studies performed specific subgroup analyses. 
Although the findings of the review support a positive association between PA and QOL in 
long-term CRC survivors, the evidence is limited as most studies were based on a cross-
sectional and observational design and no intervention studies were included. 
To my knowledge, three review articles (Cramer et al., 2014; Lynch et al., 2016; Otto et al., 
2015) have been published on the associations between PA and QOL in CRC survivors. 
However, the articles (Cramer et al., 2014; Lynch et al., 2016; Otto et al., 2015) published 
so far were based on studies which mainly included short-term CRC survivors and no 
systematic review has specifically focused on long-term CRC survivors. The results which 
were found in this systematic review are quite homogenous. Eight of the ten included 
articles found positive associations between PA and QOL, whereas the results of the 
previous reviews are more inconsistent. In line with my findings, Lynch et al. who included 
short-term and long-term survivors, also reported associations between PA and QOL in 
observational studies, although the evidence was much weaker from intervention studies 
(Lynch et al., 2016). The review article and meta-analysis of Otto et al., which focused on 
short-term CRC survivors, found a positive association between PA and QOL which was 
reported to be stable over time (Otto et al., 2015). In contrast, the review article and meta-
analysis of Cramer et al., which included only short-term survivors, did not find an 
association between PA and QOL (Cramer et al., 2014). The inconsistent findings between 
my review and the previous review articles might be explained in parts by the different study 
population characteristics. The most obvious difference is the varying time since diagnosis. 
Due to the heterogeneous findings, it remains unclear whether the overall effect of PA on 
QOL differs for short-term and long-term CRC survivors. 
Even though the majority of the studies included in my review had large sample sizes, were 
population-based, examined possible confounding factors like age, sex, and comorbidities 
and used validated QOL and PA questionnaires, most of the included studies have some 
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shortcomings which might limit their contributions to existing evidence. Nine of ten included 
articles assessed the association between PA and QOL using a cross-sectional design. For 
these studies no causality can be assumed, only an association between PA and QOL at 
one point in time. Moreover, only few studies reported results stratified by important 
covariates such as age, sex, or treatment. Although the focus of this review was on long-
term CRC survivors, only two studies (Rodriguez et al., 2015; Thraen-Borowski et al., 2013) 
were identified that solely included long-term CRC survivors. All other studies included 
short- and long-term survivors with a mean of five or more years since diagnosis. Thus, 
results of my review are in parts not only based on long-term CRC survivors. 
A further limitation of the included studies is that the majority used self-reported PA 
measures. Only one study (van Roekel et al., 2016) used an activity monitor to assess PA. 
In this context, information bias such as reporting bias might occur in studies relying on self-
reported PA or only assessing leisure time PA, but not work-related PA. Furthermore, there 
were differences in the measurement tools used to assess QOL, which may also introduce 
information bias. Some studies (Chambers et al., 2012b; Husson et al., 2015; Mols et al., 
2015; van Roekel et al., 2015; van Roekel et al., 2016) used cancer-specific QOL 
questionnaires and other studies (Blanchard et al., 2008; Blanchard et al., 2010; Blanchard 
et al., 2004; Rodriguez et al., 2015; Thraen-Borowski et al., 2013) used general QOL 
instruments. Therefore the differences in the QOL assessment might limit the comparability 
of the results. In addition, many QOL instruments specifically designed for cancer patients 
under active treatment, such as the QLQ-C30 and the Functional Assessment of Cancer 
Therapy-Colorectal Cancer (FACT-C), with their supplementary condition-specific or 
symptom-specific modules, are not entirely appropriate or sufficient for assessing the 
experience of disease free cancer survivors. 
Furthermore, the sensitivity of QOL instruments and scales to detect subtle differences in 
QOL may have had an impact on the results. For example, two of the included articles 
(Blanchard et al., 2010; Chambers et al., 2012b) did not find any association between PA 
and QOL. An explanation for the non-significant results in the article of Chambers et al. 
(Chambers et al., 2012b) might be the use of particular questionnaires (FACT-C, 
Satisfaction with Life Scale [SWLS]), which might not be sufficiently sensitive. The other 
article (Blanchard et al., 2010) not finding significant associations is based on the same 
study population as another included article (Blanchard et al., 2008) which found 
associations between PA and QOL. However, the article of Blanchard et al. which did not 
report significant results (Blanchard et al., 2010), did not present the results for the general 
associations of PA with QOL again, but only reported the association between PA and QOL 
stratified by BMI. Therefore BMI might have been a confounding factor.  
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4.2. Analyses within the DACHS study 
The discussion of the analysis on PA and QOL and the analysis on PA and fatigue are in 
parts similar due to methodological and content-related overlaps of the analyses. 
4.2.1. Association between physical activity and quality of life 
The results of this analysis do not support a positive association between pre-diagnosis PA 
and long-term QOL in CRC survivors. Pre-diagnosis work-related PA and vigorous PA might 
even decrease some QOL domains such as cognitive and emotional functioning. 
Consequently, pre-diagnosis PA does not seem to provide a buffer which may mitigate or 
prevent cancer-related detriments in QOL among long-term CRC survivors. In contrast, 
post-diagnosis PA was strongly associated with improved QOL five years after diagnosis. 
Also, survivors being physically active both pre- and post-diagnosis and survivors who 
increased their PA from pre- to post-diagnosis had a significantly higher long-term QOL 
compared to survivors being inactive pre- and post-diagnosis. The results support and 
emphasize the need of maintaining PA after CRC diagnosis. However, the cross-sectional 
results should be interpreted with caution due to possible reverse causality. 
To my knowledge, so far no other study has investigated the association of pre-diagnosis 
PA with QOL five years after CRC diagnosis. Earlier studies found a significant, positive 
association between PA and QOL in CRC survivors after treatment (Buffart et al., 2012; 
Grimmett et al., 2011; Lynch et al., 2008; Vallance et al., 2015) and also multimodal 
prehabilitation programs improved the physical and psychological health of cancer patients 
(Silver and Baima, 2013). Therefore, I hypothesized that also pre-diagnosis PA might be 
beneficial for the QOL of CRC survivors five years after diagnosis. However, the results do 
not support a positive association between pre-diagnosis PA and long-term QOL. The 
findings even suggest that pre-diagnosis work-related PA and also vigorous PA might be 
associated with poorer long-term QOL on domains such as emotional and cognitive 
functioning, fatigue, insomnia, and financial difficulties. Thus, CRC survivors who had a job 
requiring hard physical work may still suffer from these impairments on functional- and 
symptom-related QOL even years after CRC diagnosis. Although analyses were adjusted 
for education, another possible explanation for these findings could be residual confounding 
such as low socioeconomic status (working class jobs with less autonomy and lower pay). 
The cross-sectional findings regarding the association between post-diagnosis PA and QOL 
at 5YFU among long-term CRC survivors confirm previous findings which reported PA to 
be positively associated with QOL in CRC survivors. In line with my results, Husson et al. 
and Mols et al. reported positive associations of PA with global QOL and all functioning 
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scales of the QLQ-C30 (Husson et al., 2015; Mols et al., 2015). Comparable to my findings, 
Husson et al. also found differences of ≥10 points for global QOL and almost all functioning 
scales (Husson et al., 2015). 
In line with previous findings (Husson et al., 2015; Mols et al., 2015; Rodriguez et al., 2015; 
Thraen-Borowski et al., 2013), physical functioning was one of the scales most strongly 
associated with QOL in this analysis. Due to the substantial overlap between the constructs 
physical functioning and PA, this apparent association may partly represent an artifact. 
The results regarding changes in PA support the cross-sectional findings on post-diagnosis 
PA and QOL and the assumption that ongoing PA may be important for the QOL of CRC 
survivors. Only active maintainers and increasers had a significantly higher long-term QOL 
compared to inactive maintainers, but no differences in QOL were found for survivors 
decreasing their PA levels. Compared to inactive maintainers, decreasers scored even 
worse on some symptom scales such as dyspnoea, insomnia, and diarrhoea. These 
findings may be explained by decreasers having a more severe health condition following 
CRC diagnosis and treatment which prevents them from maintaining PA levels compared 
to inactive maintainers who reported to be physically inactive pre- and post-diagnosis. 
Quality of life has been shown to be positively associated with survival (Montazeri, 2009). 
Although a recent analysis using DACHS data found significant associations between pre-
diagnosis PA and overall and CRC-specific survival (Walter et al., 2017), I did not find an 
association between pre-diagnosis PA and QOL. The variation in the results might be 
explained by differences in PA classification since Walter et al. only included leisure time 
PA in their main analyses and not work-related PA as I did. In subgroup analyses comparing 
different domains of PA, I also found significant and positive associations between pre-
diagnosis leisure time PA and global QOL, physical, and cognitive functioning. However, 
the findings might not be completely comparable since inclusion of participants (in this 
analysis only survivors who survived five years were included), sample sizes, and covariate 
adjustment differed. 
Contrarily to my prior hypothesis, the results indicate that pre-diagnosis PA does not provide 
any protection for detriments in QOL five years after diagnosis, but clearly emphasize the 
importance of post-diagnosis PA for the QOL of long-term CRC survivors five years after 
diagnosis. Thus, these findings suggest that pre-diagnosis PA cannot replace ongoing PA 
after diagnosis under the assumption that the association between ongoing PA and better 
QOL is not entirely a result of reverse causality. 
In addition to the positive results of this analysis regarding post-diagnosis PA and QOL 
among long-term survivors, findings from other studies assessing PA shortly after treatment 
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also found positive associations between PA and QOL (Bourke et al., 2011; Lewis et al., 
2014; Lynch et al., 2008; Vallance et al., 2014). Moreover, one randomized trial reported 
positive effects of PA during cancer treatment such as an increased fitness capacity and 
reduced fatigue (Medscape, 2018). However, although pertinent studies have not found 
significant associations between prehabilitation programs including PA and QOL, they 
reported improvements in other important health outcomes such as fitness capacity (Gillis 
et al., 2014; Li et al., 2013; Singh et al., 2017). 
Since studies have suggested that PA at all points in time after diagnosis seem to be 
beneficial for CRC survivors, effective PA motivation techniques at an early stage after 
diagnosis and consistently repeated throughout the years of survival may help to improve 
the well-being of CRC patients. Although in this analysis pre-diagnosis work-related PA and 
vigorous PA in the years prior to CRC diagnosis were negatively associated with long-term 
QOL among CRC survivors, individually-tailored PA interventions throughout the years of 
survivorship might also be beneficial for this population. Health care providers should inform 
patients for example about the beneficial associations between light PA and QOL (Thraen-
Borowski et al., 2013; van Roekel et al., 2015). 
Although guidelines such as the S3-guideline “colorectal cancer” point out the necessity for 
physicians to recommend PA to CRC patients (Schmiegel et al., 2017), oncologists often 
do not prescribe PA to cancer patients (Sabatino et al., 2007; Spellman et al., 2013). 
Reasons which hinder health care providers from recommending PA to cancer patients 
include lack of time, lack of reimbursement, and lack of exercise programs for cancer 
patients as well as safety concerns (Haussmann et al., 2018; Karvinen et al., 2010; Park et 
al., 2015; Spellman et al., 2013). However, it has been shown that oncologists´ 
encouragement to engage in PA is crucial for cancer patients to participate in PA 
interventions (Eggly et al., 2008; Jones et al., 2004). Therefore, it is important that health 
care providers motivate and encourage cancer survivors to be physically active also in the 
years of survivorship. Also, more supervised exercise programs which focus on the specific 
needs of CRC survivors throughout the years of survivorship would be beneficial. 
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4.2.2. Association between physical activity and fatigue 
For the analysis on PA and fatigue, a comparable pattern of results, similar to the analysis 
on PA and QOL, was found. Higher levels of pre-diagnosis PA did not seem to mitigate 
fatigue of CRC survivors five years after diagnosis. Pre-diagnosis work-related PA and 
vigorous PA were even associated with higher physical, cognitive, and affective fatigue. In 
contrast, post-diagnosis PA was strongly associated with lower physical, cognitive, and 
affective fatigue. Moreover, survivors being physically active pre- and post-diagnosis and 
survivors becoming physically active post-diagnosis scored significantly lower on all fatigue 
scales compared to survivors who remained inactive from pre- to post-diagnosis. The 
results of this analysis point out the importance of ongoing PA throughout CRC survivorship, 
particularly for fatigue, which is the symptom most frequently reported among cancer 
patients. However, the cross-sectional results should be interpreted with caution due to 
possible reverse causality. 
To my knowledge, so far, no other study has investigated associations between pre-
diagnosis PA and fatigue five years post-diagnosis. Prehabilitation programs including PA 
before cancer treatment and studies assessing PA after treatment found PA to be beneficial 
for CRC survivors´ physical and psychological health. Therefore, it was hypothesized that 
pre-diagnosis PA might also be advantageous for fatigue in long-term CRC survivors. 
However, in line with my previous findings on pre-diagnosis PA and QOL, no beneficial 
effects of pre-diagnosis PA on long-term fatigue were found, and higher levels of pre-
diagnosis work-related PA and vigorous PA were even positively associated with all fatigue 
scales. Therefore, it is assumed that survivors who had a physically demanding job before 
cancer diagnosis might not only have detriments in QOL, but also suffer from fatigue years 
after their CRC diagnosis. However, residual confounding, for example by lower 
socioeconomic status (working class jobs with less autonomy and lower pay) could be 
another possible explanation for these findings. 
The results regarding changes in PA support the cross-sectional findings on post-diagnosis 
PA and fatigue, and the assumption that ongoing PA may be important for fatigue of long-
term CRC survivors. Only active maintainers and increasers had a significantly lower long-
term fatigue compared to inactive maintainers, but no differences in fatigue were found for 
survivors decreasing their PA levels. These findings may be explained by decreasers 
having a more severe health condition following CRC diagnosis and treatment which 
prevents them from maintaining PA levels compared to inactive maintainers who reported 
to be physically inactive pre- and post-diagnosis. 
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In line with my findings, several observational studies reported post-diagnosis PA to be 
associated with lower fatigue in CRC survivors (Breedveld-Peters et al., 2018; Grimmett et 
al., 2011; Mols et al., 2015; Peddle et al., 2008; van Roekel et al., 2015). However, a recent 
systematic review which performed a meta-analysis of randomized controlled trails, failed 
to show a significant association between PA and fatigue among CRC survivors, although 
in all studies PA was accompanied by reduced levels of fatigue. Further, inconclusive 
results regarding the association between PA and fatigue for observational prospective 
studies were reported. The review concludes that some of the trials might not have been 
appropriately powered to detect differences in fatigue (Brandenbarg et al., 2018). 
Although a multidimensional concept of fatigue is well accepted, most studies 
unidimensionally assessed the association between PA and physical fatigue. Therefore, 
studies might have missed some aspects of fatigue such as cognitive or affective fatigue 
and thus only few findings regarding the association of PA with multiple fatigue scales exist. 
Moreover, it has been discussed that the different fatigue dimensions might not be 
expressions of one symptom but rather expressions of independent symptoms (de Raaf, 
2013) since some fatigue dimensions have been observed to behave differently (de Raaf 
et al., 2013). Also, specific subtypes of cancer-related fatigue among long-term CRC 
survivors were identified (Thong et al., 2018). Based on these findings it can be concluded 
that survivors might benefit from interventions targeted to the personal fatigue experience. 
For example, cancer survivors suffering from physical fatigue might benefit more from being 
physically active than survivors suffering from cognitive or affective fatigue for which 
interventions such as mental training or psychosocial interventions might be more 
beneficial. Although my results show that post-diagnosis PA was strongly associated with 
all fatigue scales, the association was lowest for PA and cognitive fatigue. Thus, it could be 
hypothesized that survivors who reported higher levels of cognitive fatigue would have 
benefitted from additional mental training or psychosocial interventions. 
So far most studies focused on fatigue shortly after CRC diagnosis. However, as mentioned 
in section 1.2.4, it has been reported that fatigue can persist years after diagnosis. 
Therefore, it is important to find out if PA is beneficial to mitigate long-term fatigue of CRC 
survivors. The findings of this analysis add to current knowledge that pre-diagnosis PA 
cannot replace ongoing PA after diagnosis among long-term CRC survivors, under the 
assumption that the association between ongoing PA and better fatigue is not entirely a 
result of reverse causality. 
Fatigue is often reported as the symptom most burdensome among cancer survivors (Ryan 
et al., 2007) and it has been shown to affect QOL more than other symptoms such as pain 
or depression (Cheng and Lee, 2011; Hofman et al., 2007). Since fatigue can persist over 
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years of survivorship (Thong et al., 2013), it is of great relevance to find out more about 
interventions that have the potential to decrease fatigue in CRC survivors, also in the long 
run. Contrary to my prior hypothesis, pre-diagnosis PA was not associated with lower fatigue 
and does not seem to provide a buffer for fatigue in the years after CRC diagnosis. Instead, 
ongoing PA after CRC diagnosis might be important to mitigate fatigue among long-term 
CRC survivors. Therefore, based on these results, health care providers should encourage 
CRC survivors to be physically active in survivorship, regardless of pre-diagnosis PA levels. 
Although pre-diagnosis work-related PA and vigorous PA in the years prior to CRC 
diagnosis were positively associated with long-term fatigue among CRC survivors, 
individually-tailored PA interventions throughout the years of survivorship might also be 
beneficial for this population. Health care providers should inform patients for example 
about the beneficial associations not only between light PA and QOL but also about the 
beneficial associations of light PA and fatigue among cancer survivors (Serda et al., 2018; 
van Roekel et al., 2015). Despite the reasons which may hinder health care providers from 
recommending PA to cancer survivors, as mentioned in section 4.2.1, it is important that 
health care providers motivate cancer survivors to be physically active also in the years of 
survivorship. Moreover, the provision of more supervised exercise programs which focus 
on the specific needs of the population of CRC survivors throughout the years of 
survivorship would be beneficial. 
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4.2.3. Potential determinants of physical inactivity 
Since the findings of the first two analyses suggest that ongoing PA seems to be relevant 
for the well-being of long-term CRC survivors, an analysis was conducted to investigate 
potential barriers of PA among long-term CRC survivors. A number of factors such as 
having a stoma, living in a small town or city, older age, being divorced, a current smoker, 
and obese were associated with higher odds of physical inactivity at 5YFU with minor 
variations regarding the strength and significance of each specific association. Survivors 
who were physically active at baseline were less likely to be physically inactive at 5YFU. 
Participants drinking small amounts of alcohol at 5YFU were more likely to be physically 
inactive, and survivors reporting a high alcohol consumption at 5YFU were less likely to be 
physically inactive. No associations were found for sex, citizenship, education, cancer site, 
or primary treatment. Some associations between patient characteristics and physical 
inactivity might be restricted to subgroups according to age and sex. 
A few studies such as Fisher et al. (Fisher et al., 2016), McGowan et al. (McGowan et al. 
2013), and van Putten et al. (van Putten et al. 2016) have already investigated potential 
determinants of physical inactivity among CRC survivors, but to my knowledge, this is the 
first study which investigated potential determinants of physical inactivity specifically in long-
term CRC survivors. Comparable to the results of my analysis, van Putten et al. (van Putten 
et al. 2016) and Fisher et al. (Fisher et al. 2016) identified older age as a barrier for PA in 
CRC survivors. Moreover, van Putten et al. (van Putten et al. 2016) also reported that 
obesity was associated with lower PA among CRC survivors. In accordance with my results, 
other studies also did not find any cancer site-specific (McGowan et al., 2013; van Putten 
et al., 2016), cancer treatment-specific (Fisher et al., 2016; McGowan et al., 2013), or 
education-specific (van Putten et al., 2016) associations with physical inactivity. In contrast 
to the findings of this analysis, previous studies reported men to be more physically active 
than women (McGowan et al., 2013; van Putten et al., 2016). These differences in results 
might be explained by the different PA questionnaires used, which might have asked 
especially for PAs that are more popular among men. In the present analysis, having a 
stoma was a strong predictor of physical inactivity in long-term CRC survivors, although 
previous studies did not find stoma use to be associated with physical inactivity (McGowan 
et al., 2013; van Putten et al., 2016). Since it was observed that the association between 
having a stoma and physical inactivity was restricted to the younger age group (30-69 
years), the different results in this study compared to other studies might be explained by 
the inclusion of a higher number of younger participants having a stoma in the DACHS 
study. Younger survivors may be more afraid of the stoma leaking and thus might feel more 
ashamed going out or being physically active compared to older survivors who may be 
4 Discussion 91 
 
 
better adjusted to handling the side effects of other diseases. Moreover, younger survivors 
with a stoma might not be able to perform sports that they had done before, and thus, they 
are less physically active. In previous studies, heterogeneous results were found regarding 
the associations of comorbidity with physical inactivity (Fisher et al., 2016; van Putten et al., 
2016). In this analysis, almost all models indicated an association between having ≥2 
comorbidities and physical inactivity. However, these results are hard to compare since 
different comorbidities were assessed in previous studies and the categorization of the 
number of comorbidities was not the same. 
The results regarding alcohol were counter-intuitive at first sight. Survivors drinking small 
amounts of alcohol at 5YFU were more likely to be physically inactive, and survivors 
reporting high alcohol consumption at 5YFU were less likely to be physically inactive. A 
possible explanation for these findings could be the present health condition of those 
survivors. Participants who have fully recovered may be more physically active and able to 
participate in social life again and thus might drink more alcohol. Survivors who still suffer 
from comorbidities and long-term treatment side effects might not be physically active and 
not drinking much alcohol. 
In general, the different results in this study compared to previous studies might be caused 
by country-specific PA habits and the heterogeneity between studies regarding the inclusion 
criteria or PA assessment. Furthermore, one of the most obvious differences of this study 
compared to other studies is the exclusion of short-term CRC survivors. 
No clear distinction between healthy people and CRC survivors can be made regarding 
potential determinants of physical inactivity. In both healthy populations (Chastin et al., 
2015; Koeneman et al., 2011) and CRC survivors, studies reported heterogeneous results. 
However, having a higher BMI seemed to be associated with physical inactivity in both 
healthy populations as well as CRC survivors. 
Since PA was found to be positively associated with several health outcomes such as better 
prognosis and QOL among CRC patients, understanding the potential determinants of 
physical inactivity in the growing population of long-term CRC survivors has strong clinical 
relevance. The findings of this analysis suggest that predominantly patients having a stoma, 
living in a more populated area, being older, divorced, a current smoker, or obese were 
more likely to be physically inactive. Those survivors might suffer from problems such as 
pain or a poor psychological or physical health condition which may hinder them from being 
vigorously or moderately physically active. Health care providers could give specific PA 
advice to those patients and inform them for example about the positive associations found 
for light PA and QOL as well as fatigue (Serda et al., 2018; Thraen-Borowski et al., 2013; 
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van Roekel et al., 2015). Since results further showed that PA at baseline was significantly 
associated with PA at 5YFU, survivors being physically inactive at baseline might stay 
physically inactive in the years after CRC diagnosis. Therefore, an effective strategy to 
encourage PA in these high-need groups at an early point in time may help to reduce or 
even prevent physical inactivity in CRC survivors. 
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4.3. Strengths and limitations 
4.3.1. Systematic review of the association between physical activity and 
quality of life in long-term colorectal cancer survivors 
The systematic review has some specific strengths and limitations. Major strengths of this 
systematic review include the comprehensive search strategy in multiple databases, the 
adherence to criteria for conducting and reporting of systematic reviews, and the 
consideration of the methodological quality of the included studies. A further strength of this 
systematic review is that it is the first to summarize and evaluate the association of PA and 
QOL, specifically in long-term CRC survivors. This systematic review also has some 
shortcomings. Due to the heterogeneity of the study methods and results, pooling of the 
results was not possible and therefore no meta-analysis could be performed. Valuable 
information regarding the association between PA and QOL might have been missed by 
excluding studies that assessed QOL only on one dimension, by excluding observational 
and intervention studies which assessed the association between PA and QOL not only in 
long-term CRC survivors (mean of time since diagnosis <five years), by using databases 
which only detect published literature, or by excluding studies conducted in languages other 
than English or German. 
4.3.2. Analyses within the DACHS study 
Some overall strengths and limitations for the analyses carried out within the DACHS study 
demand careful consideration. Major strengths include a large population-based study 
sample, detailed and complete follow-up information, a prospective study design, 
comprehensive adjustment for confounders, tests for linear trends, and detailed 
investigations of differences in subgroups such as for pre-diagnosis PA, domain and 
intensity-specific evaluations. Furthermore, results of the analyses were solely based on 
long-term CRC survivors with a primary CRC diagnosis and the assessment of QOL, 
fatigue, and PA at 5YFU was performed using validated and standardized questionnaires. 
In general, the number of missing values was relatively low due to the collection of 
information by trained interviewers. For the analysis on determinants of physical inactivity, 
potential bias caused by missing values was minimized by performing multiple imputation. 
The results of the analyses performed within the DACHS study add to the limited knowledge 
about the benefits of PA and the potential determinants of physical inactivity among the 
growing population of long-term CRC survivors. 
Certain limitations should also be considered. Due to the observational and partly cross-
sectional study design, the findings can give only indirect support for recommendations of 
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encouraging and maintaining PA among long-term CRC survivors and preventing CRC 
long-term survivors from being physically inactive after diagnosis. Physical activity 
information was only available before diagnosis and five years after, therefore, it is not 
known how patients changed their PA habits over the course of their disease. Furthermore, 
since the reported PA of the last age decade (40, 50, 60 years…etc.) was used as pre-
diagnosis PA, some bias might have been introduced. For example, someone diagnosed 
with CRC at age 61 might not have been very active at age 60 due to undiagnosed 
cancer/poor health, whereas someone diagnosed with CRC at age 69 will have a measure 
of their PA nearly a decade earlier. Moreover, recall or desirability bias may have occurred 
through self-reported PA measurement at baseline and 5YFU. In addition, high baseline PA 
levels were observed which challenge the validity of the baseline PA instrument and its 
comparability with the IPAQ used at 5YFU. Although the FAQ is a validated and 
standardized fatigue questionnaire, the physical scale was not assessed and therefore for 
the analysis on fatigue, the fatigue scale from the QLQ-C30 was used, even though the 
fatigue scales might not have been fully comparable. Despite being one of the largest 
studies worldwide on long-term CRC survivors, some patient subgroups especially of the 
analysis on determinants of physical inactivity were very small and subgroup analysis 
results should be interpreted with caution. Moreover, owing to the partly cross-sectional 
design of the analyses, the results should be interpreted with caution due to possible 
reverse causality. Finally, although I adjusted for several potential confounders in all 
analyses, residual confounding cannot be ruled out.  
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4.4. Conclusion 
Physical activity has been shown to be effective in the primary prevention of CRC. Despite 
the growing interest for the role of PA in tertiary prevention, research on PA and QOL 
specifically among long-term CRC survivors is scarce. This dissertation aimed to investigate 
whether PA is associated with better QOL and to identify potential determinants that prevent 
long-term CRC survivors from being physically active. Results from the literature review 
showed that only few studies investigated the association between PA and QOL especially 
in long-term survivors. Summarizing the findings of the included studies, higher as well as 
lower intensities of post-diagnosis PA were positively associated with CRC survivors´ QOL, 
however, most studies were based on a cross-sectional and observational study design. 
In the DACHS study, PA was assessed shortly after CRC diagnosis, asking for pre-
diagnosis PA and PA five years post-diagnosis, concurrent with QOL and fatigue. 
Therefore, a prospective assessment of pre-diagnosis PA with long-term factors such as 
QOL or fatigue was feasible. Results regarding the associations between PA and QOL as 
well as PA and fatigue suggest that pre-diagnosis PA might not provide any protection of 
cancer-related detriments neither in QOL nor in fatigue among long-term CRC survivors. 
Pre-diagnosis work-related PA and vigorous PA were even associated with decreased QOL 
in some domains and increased physical, cognitive, and affective fatigue. However, the 
results of the analyses support and emphasize the need of ongoing PA after CRC diagnosis 
to improve QOL and reduce fatigue in this population. 
In a further analysis within the DACHS study, cancer-specific factors such as having a 
stoma, socio-demographic factors such as living in a small town or city, older age, or being 
divorced as well as lifestyle factors such as being a current smoker, or being obese were 
associated with physical inactivity among long-term CRC survivors. Moreover, baseline PA 
was identified as a strong predictor of physical inactivity five years later. Further subgroup 
analyses showed that the association between BMI and physical inactivity was stronger in 
women than in men. 
The results of this dissertation are promising since it can be concluded that it is never too 
late to start exercising to improve the QOL of long-term CRC survivors and that PA is 
positively associated with QOL, even if completed at low intensity. This information might 
be motivating for CRC survivors who experience the cancer disease as a teachable 
moment, and therefore are more receptive for a lifestyle change. In addition, CRC survivors 
such as older survivors or survivors with poor health who may not be able to participate in 
higher intensity PA, have the potential to improve their QOL with low intensity PA. 
Subgroups of survivors who suffer from detriments in QOL five years after diagnosis as well 
96 4 Discussion 
 
  
as groups at higher risk for post-diagnosis physical inactivity were identified. In clinical 
practice, addressing high-need groups among CRC survivors might help to contribute to the 
development of specific, individually-tailored PA interventions to overcome physical 
inactivity and improve the long-term well-being of CRC survivors. Although guidelines such 
as the S3-guideline “colorectal cancer” point out the necessity for physicians to recommend 
PA to CRC patients, health care providers often do not prescribe PA to cancer patients. 
However, the encouragement by health care providers to engage in PA is crucial for cancer 
patients to participate in PA interventions. Therefore, it is important that health care 
providers motivate and encourage cancer survivors to be physically active also in the years 
of survivorship. 
The findings of this dissertation add to the limited evidence on the crucial role of PA among 
long-term CRC survivors. However, more prospective studies and randomized controlled 
trials are needed to further evaluate and confirm the causality of the findings, in order to 
provide more solid evidence for individual PA recommendations and strategies to overcome 
barriers to PA. Moreover, prospective studies should focus on the association between PA 
and QOL or fatigue at multiple points in time pre- and post-diagnosis to determine if and 
how the effect of the association changes. In addition, future studies should complement 
self-reported PA information by using objective activity monitoring to minimize reporting 
bias. Future studies may also consider incorporating QOL questionnaires that cover 
psychological as well as physical aspects specifically relevant for long-term cancer 
survivors to gain a greater understanding of the specific needs relevant for this population. 
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5. SUMMARY 
Colorectal cancer is the third most common cancer and the second most common cause of 
cancer-related death worldwide. Early detection and improvements in treatment as well as 
the aging and growth of the population have substantially contributed to the increasing 
number of long-term (five or more years after diagnosis) colorectal cancer survivors. 
However, many colorectal cancer survivors experience detriments in quality of life in the 
years well beyond their diagnosis and quality of life is affected by fatigue more than by other 
symptoms. Thus, improving the quality of life and reducing fatigue of the increasing 
population of long-term colorectal cancer survivors has strong clinical and population health 
relevance. Evidence has accumulated that physical activity is prognostically relevant for 
colorectal cancer survivors and studies further reported positive associations between 
physical activity and quality of life among this population. However, so far studies have 
mainly focused on short-term colorectal cancer survivors. 
A systematic review was conducted to summarize the current state of research with respect 
to the association between physical activity and quality of life in long-term colorectal cancer 
survivors. Only two of the seven included studies were restricted to long-term survivors, the 
other studies comprised survivors with a mean of five or more years since diagnosis. The 
results of this review demonstrate that long-term colorectal cancer survivors who were more 
physically active after diagnosis generally reported higher quality of life than non-active 
survivors. Moreover, different activity intensities such as light and moderate to vigorous 
physical activity were positively associated with quality of life in long-term colorectal cancer 
survivors. Further, the association between physical activity and quality of life appeared to 
be stronger among women than among men. Although the findings of this systematic review 
support a positive association between physical activity and quality of life in long-term 
colorectal cancer survivors, the evidence is limited as most studies were based on a cross-
sectional and observational design. 
The findings of the systematic review were confirmed and extended in the analyses among 
long-term colorectal cancer survivors of the DACHS study. The DACHS study is a 
population-based study with ongoing follow-up. In addition to the results of the review, the 
analysis of the DACHS data revealed no positive association between pre-diagnosis 
physical activity and long-term quality of life in colorectal cancer survivors. Pre-diagnosis 
work-related physical activity and vigorous physical activity might even decrease some 
quality of life domains such as cognitive and emotional functioning. Consequently, pre-
diagnosis physical activity does not seem to provide a buffer that may mitigate or prevent 
cancer-related detriments in quality of life among long-term colorectal cancer survivors. In 
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contrast, post-diagnosis physical activity was strongly associated with quality of life five 
years after diagnosis in line with the findings of the review. Also, survivors being physically 
active both pre- and post-diagnosis and survivors who increased their physical activity from 
pre- to post-diagnosis had a significantly higher long-term quality of life compared to 
survivors being inactive pre- and post-diagnosis. Due to the important role of fatigue in the 
context of quality of life, the association between pre- and post-diagnosis physical activity 
and long-term physical, cognitive, and affective fatigue was evaluated. Although, a positive 
association between pre-diagnosis work-related physical activity as well as vigorous 
physical activity and long-term physical, cognitive, and affective fatigue was found, post-
diagnosis physical activity was strongly associated with reduced levels of fatigue on all 
scales. Also, survivors who remained physically active from pre- to post-diagnosis and 
survivors becoming physically active post-diagnosis, scored significantly lower on all fatigue 
scales compared to non-active survivors pre- and post-diagnosis. The results of both 
analyses support and emphasize the need of maintaining physical activity after colorectal 
cancer diagnosis. However, the cross-sectional results should be interpreted with caution 
due to possible reverse causality. 
Since physical activity has been shown to be associated with better prognosis and quality 
of life in colorectal cancer patients, an analysis was conducted which focused on the barriers 
of physical activity among long-term colorectal cancer survivors. A number of factors such 
as having a stoma, living in a small town or city, older age, being divorced, a current smoker, 
or obese were associated with higher odds of physical inactivity five years post-diagnosis. 
Further, baseline physical activity was a strong predictor for physical activity five years later. 
In conclusion, the findings of this dissertation add to the limited evidence on the crucial role 
of physical activity among long-term colorectal cancer survivors and its positive association 
with quality of life. Further, the results may be used to target high-need groups for post-
diagnosis physical inactivity. However, more prospective studies and randomized controlled 
trials are needed to further evaluate and confirm the causality of the findings, in order to 
provide more solid evidence for individual physical activity recommendations and strategies 
to overcome barriers to physical activity. Moreover, prospective studies should focus on the 
association between physical activity and quality of life or fatigue at multiple points in time 
pre- and post-diagnosis to determine if and how the effect of the association changes. In 
addition, future studies should complement self-reported PA information by using objective 
activity monitoring to minimize reporting bias. Future studies may also consider 
incorporating quality of life questionnaires that cover psychological as well as physical 
aspects specifically relevant for long-term cancer survivors to gain a greater understanding 
of the specific needs relevant for this population.  
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ZUSAMMENFASSUNG 
Darmkrebs als dritthäufigste Krebsart ist für jeden zweiten Krebstod weltweit verantwortlich. 
Früherkennung, verbesserte Therapiemöglichkeiten sowie das Älterwerden und Wachstum 
der Bevölkerung haben maßgeblich dazu beigetragen, dass sich die Anzahl der langzeit-
überlebenden Darmkrebspatienten (fünf Jahre nach Diagnose oder länger) kontinuierlich 
erhöhte. Viele Darmkrebspatienten erleben jedoch noch lange nach ihrer Diagnose 
Einbußen in der Lebensqualität (dabei ist Fatigue ein Symptom, das sich besonders negativ 
auf die Lebensqualität von Krebspatienten auswirkt). Demzufolge ist die Verbesserung der 
Lebensqualität als auch die Verringerung von Fatigue von langzeitüberlebenden 
Darmkrebspatienten von großer klinischer Relevanz. Evident ist, dass körperliche Aktivität 
bzgl. Darmkrebs prognostisch relevant ist und zudem positiv mit Lebensqualität assoziiert 
ist. Bisherige Studien beziehen sich allerdings fast ausschließlich auf den Zusammenhang 
zwischen körperlicher Aktivität und Lebensqualität bei Darmkrebspatienten binnen der 
ersten fünf Jahre nach Diagnose. 
Um den aktuellen Wissensstand in Bezug auf den Zusammenhang zwischen körperlicher 
Aktivität und Lebensqualität bei langzeitüberlebenden Darmkrebspatienten aufzuzeigen 
wurde ein systematischer Review durchgeführt. Darin zeigte sich, dass sowohl höhere als 
auch niedrigere Intensitäten körperlicher Aktivität positiv mit der Lebensqualität von 
langzeitüberlebenden Darmkrebspatienten assoziiert waren. Zudem schien dieser 
Zusammenhang bei Frauen stärker zu sein als bei Männern. Allerdings ist die Aussagekraft 
des systematischen Reviews begrenzt, da er hauptsächlich auf querschnittlichen 
Beobachtungsstudien beruht und nur zwei der sieben einbezogenen Studien sich 
ausschließlich auf Langzeitüberlebende fokussierten. 
In anschließenden Auswertungen wurden anhand der Daten aus der bevölkerungs-
bezogenen DACHS-Studie, mit Follow-up fünf Jahre nach Diagnose, die Ergebnisse des 
Reviews bestätigt und erweitert. Es zeigte sich keine positive Assoziation zwischen 
körperlicher Aktivität vor Diagnose und der Lebensqualität von Überlebenden fünf Jahre 
nach Diagnose. Arbeitsbedingte und schwere körperliche Aktivität vor Diagnose gingen 
sogar mit Beeinträchtigungen in einigen Lebensqualitätsbereichen einher. Insgesamt 
scheint also körperliche Aktivität vor Diagnose die Folgen von krebsbedingten Beeinträchti-
gungen in der Lebensqualität von langzeitüberlebenden Darmkrebspatienten weder zu 
verhindern noch abzumildern. Im Gegensatz dazu war körperliche Aktivität fünf Jahre nach 
Diagnose stark mit verbesserter Lebensqualität assoziiert. Darüber hinaus hatten 
Überlebende, die sowohl vor als auch nach Diagnose körperlich aktiv waren sowie 
Überlebende, die ihre körperliche Aktivität nach der Diagnose steigerten, eine signifikant 
höhere Lebensqualität als inaktive Überlebende vor und nach Diagnose. 
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Aufgrund der großen Bedeutung von Fatigue in Hinblick auf die Lebensqualität von Krebs-
patienten wurde gezielt die Assoziation zwischen körperlicher Aktivität sowohl vor als auch 
nach Diagnose und Fatigue untersucht. Dabei zeigte sich analog der vorherigen 
Auswertung eine starke Assoziation zwischen körperlicher Aktivität nach Diagnose und 
signifikant verringerter körperlicher, kognitiver und affektiver Fatigue. Auch Überlebende, 
die vor und nach Diagnose körperlich aktiv waren und Überlebende, die nach Diagnose 
körperlich aktiv wurden, wiesen auf allen Fatigueskalen einen signifikant niedrigeren Wert 
auf als inaktive Überlebende vor und nach Diagnose. Die Ergebnisse beider Analysen 
unterstreichen die Notwendigkeit körperlicher Aktivität nach einer Darmkrebsdiagnose. Die 
querschnittlichen Assoziationen zwischen körperlicher Aktivität und Lebensqualität als auch 
Fatigue sollten jedoch wegen möglicher reverser Kausalität mit Vorsicht interpretiert 
werden. 
Da gezeigt werden konnte, dass körperliche Aktivität neben einer verbesserten Prognose 
mit verbesserter Lebensqualität von Darmkrebspatienten assoziiert ist, wurde eine weitere 
Analyse durchgeführt, die sich mit den Barrieren körperlicher Aktivität bei langzeit-
überlebenden Darmkrebspatienten befasste. Eine Reihe von Faktoren, wie das Leben mit 
einem Stoma, das Wohnen in einer bevölkerungsreicheren Gegend, ein höheres 
Lebensalter, Scheidung, Rauchen oder Fettleibigkeit waren fünf Jahre nach Diagnose mit 
einer höheren Wahrscheinlichkeit körperlicher Inaktivität assoziiert. Darüber hinaus war die 
körperliche Aktivität vor Diagnose ein starker Prädiktor bezüglich der körperlichen Aktivität 
fünf Jahre nach Diagnose. 
Die Ergebnisse dieser Dissertation ergänzen den aktuellen Forschungstand bzgl. der 
zentralen Rolle von körperlicher Aktivität für die Lebensqualität von langzeitüberlebenden 
Darmkrebspatienten. Darüber hinaus könnten die Ergebnisse genutzt werden, um Risiko-
gruppen für körperliche Inaktivität gezielt zu unterstützen. Weitere prospektive und 
randomisierte kontrollierte Studien sind jedoch erforderlich, um mehr über die kausalen 
Zusammenhänge der gefundenen Ergebnisse aussagen zu können und um somit eine 
solide Grundlage für Empfehlungen zur körperlichen Aktivität und für Strategien zur Über-
windung von körperlicher Inaktivität bereitzustellen. Darüber hinaus sollten prospektive 
Studien die Assoziation zwischen körperlicher Aktivität und Lebensqualität oder Fatigue zu 
mehreren Zeitpunkten vor und nach Diagnose untersuchen, um zu bestimmen, ob und in 
welcher Weise sich der Effekt der Assoziation verändert. Zukünftige Studien sollten 
objektive Messungen von körperlicher Aktivität und auch Lebensqualitätsfragebögen in 
Betracht ziehen, die sowohl psychische als auch körperliche Aspekte abdecken, welche 
speziell für langzeitüberlebende Krebspatienten relevant sind. 
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8. APPENDICES 
Appendix I Search terms systematic review 
The following combinations of search terms were used:  
(colorectal cancer OR colorectal neoplasms OR colorectal carcinoma OR colon cancer OR colon 
carcinoma OR rectal cancer OR rectal carcinoma OR rectal neoplasms OR colonic neoplasms OR 
intestinal cancer OR intestinal neoplasms OR lower gastrointestinal tract OR bowel cancer)  
AND  
(quality of life OR well-being OR mental health OR QOL OR HRQOL OR life quality OR qualities of 
life OR life satisfaction OR personal satisfaction)  
AND  
(motor activity OR physical activity OR exercise OR sedentary lifestyle) 
 
In the database PubMed, the following Mesh terms were used additionally:  
(colorectal neoplasms OR intestinal neoplasms OR colon OR rectum OR rectal neoplasms OR 
colonic neoplasms OR lower gastrointestinal tract)  
AND  
(quality of life OR mental health OR personal satisfaction)  
AND  
(motor activity OR exercise OR sedentary lifestyle) 
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 Appendix II Association of physical activity and quality of life - symptom scales 
 Statistical significance (p<0.05) and clinical relevance 
+/–: significant positive/negative association  
ns: not statistically significant 
a,b,cclinical relevance 
Study QLQ-C30 Pain Fatigue Nausea,  
Vomiting 
Appetite 
loss 
Constipation Diarrhoea Dyspnoea Insomnia Financial 
difficulties 
Mols 
(2015) 
Meeting vs. not meeting PA 
recommendations 
Low neuropathyd ‒a ‒ ns ‒ ns ‒a ‒a ns ns 
 Meeting vs. not meeting PA 
recommendations 
High neuropathye ‒a ‒a ns ‒ ns ‒a ‒a ns ns 
 Meeting vs. not meeting PA 
recommendations ‒ ‒ ns ‒ ns ‒ ‒ ns ns 
QOL: quality of life; QLQ-C30: Quality of Life Questionnaire-Core 30; PA: physical activity; PA recommendations: 150 minutes of moderate intensity exercise each week or 75 minutes of vigorous 
intensity activity each week or an equivalent combination of both; QLQ-CIPN20: Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy; aclinical importance reported by authors; 
bcalculated by RE; cno values, no cut-off for calculation available; d70% of patients with lowest scores of QLQ-CIPN20; e30% of patients with highest scores of QLQ-CIPN20 
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Appendix III Relevant section from the DACHS study baseline questionnaire: physical 
activity 
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Appendix IV Relevant section from the DACHS study five-year follow-up questionnaire: 
quality of life (QLQ-C30) 
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Appendix V Relevant section from the DACHS study five-year follow-up questionnaire: 
fatigue (FAQ) 
 
  
128 8 Appendices 
 
 
 
8
   A
p
p
e
n
d
ic
e
s
 
  
 
8
   A
p
p
e
n
d
ic
e
s
 
  
 
8
   A
p
p
e
n
d
ic
e
s
 
  
 
8
   A
p
p
e
n
d
ic
e
s
 
 
Appendix VI Relevant section from the DACHS study five-year follow-up questionnaire: 
physical activity (IPAQ Short Form) 
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